BICLUSTER_ID : UPREG-0
PATHOGENS /1/ : ehrlichia chaffeensis
TARGETS /186/ : SYK, LCN2, CD44, ANXA2, HCK, PSAT1, CYSLTR2, IFNG, SDHC, NDUFA8, NDUFS6, XDH, PLG, CCL8, MUT, SAA2, NDUFS2, CYP27A1, SLC38A3, SERPINE1, DECR1, CXCR4, ARG2, BCL2, MTHFD1, GLS, ASGR2, SERPINB2, VCAM1, NDUFA10, CCL5, GP1BA, GLUD1, CYB5A, ADRBK1, AZGP1, GNG2, ANXA1, IFNGR1, HMOX1, ACAT2, HPD, ALDH6A1, ITGB2, NDUFB6, HSD17B4, TLR2, TNF, PROS1, FGFR4, LCK, NDUFB8, BDH1, ASS1, NDUFS1, CD52, TGFB1, UQCRC1, PTPN1, EDNRA, PET112L, NDUFAB1, F9, FYN, NDUFS3, ICAM1, PTK2B, PLA2G4A, ALDH1A1, SDHB, JUN, ATP5D, ACSL1, CD40, TNFRSF1B, PTGIR, CAT, F13A1, SLC7A1, GPR18, SERPINF2, MPO, GZMB, PRKCQ, PPBP, SELP, GSTZ1, WARS, APOB, TAP1, LTB, HMGCL, ITGA2B, CSF3R, F5, PTGER2, PLAUR, CA2, NDUFA3, ELA2, ACADSB, KIT, ALDOA, DAPP1, ISG20, RBP4, CD86, IL2RB, JAK2, IL6R, PDGFRA, SORD, MCM6, TNFRSF1A, KYNU, CASP1, IL1R1, NDUFC1, ANXA3, FBP1, GPT, CCR5, HRSP12, PYGL, ADH4, NDUFS7, CCL2, CD22, PROCR, CD80, GLA, SLC1A5, OTC, NNMT, SHMT1, AMPD3, F2, COL1A1, CD55, S100A11, ADA, GGCX, STAT1, ACAT1, NDUFA9, PCCB, IFNGR2, NDUFA4, CSF2RA, IL6, SDHD, PLAT, PIK3CG, SDHA, MTTP, CYP1B1, GHR, CBS, NDUFB5, SAT1, PRKCB1, ABCC1, FCGR3A, ITGB3, GP9, IL1B, SELE, VWF, ABCC4, IL3RA, ADRBK2, AGXT, PROC, PF4, IL12B, WAS, THBD, FCER1G, ALDH2, IL2RG, F11, APOH, BTK, GRB2, HSD11B1, ITGA4
Gene SetLeading Edge Genes
HSIAO LIVER SPECIFIC GENESACADSB, CPS1, PRDX4, APOC4, SLC2A2, HGD, PZP, PCBD1, RBP4, ITIH1, ACSM3, PLG, MUT, AOX1, ALDOB, SORD, CYP27A1, ABCC6, DDT, FAH, KYNU, SLC38A3, SEPP1, DECR1, GPT, FBP1, HRSP12, PYGL, ADH4, MTHFD1, ASGR2, AADAC, OTC, ATP13A3, AKR1D1, F2, SHMT1, SEPHS2, SPP2, GLUD1, CYB5A, AZGP1, GGCX, ACAT1, PCCB, ACAT2, ALDH6A1, HMGCS2, HPD, APOC1, ASGR1, AHSG, HSD17B4, CFHR1, FABP1, FGFR4, PCSK6, C8A, RGN, APOC2, MTTP, HRG, EPHX1, HABP2, BDH1, ASS1, GHR, CBS, C8B, FURIN, TST, TAF6, DPYS, APOF, APOC3, F9, DAB2, G6PC, ALDH1A1, SOD1, CPN2, ACSL1, ADFP, LAMP2, HGFAC, CAT, CYP2E1, SLC10A1, LSR, AGXT, ACAA2, SERPINF2, PROC, LIPC, GSTZ1, APOB, ALDH2, HMGCL, PGRMC1, KLKB1, SERPINF1, F5, F11, CDH2, APOH, TDO2, GJB1, HSD11B1
MOOTHA VOXPHOSBCS1L, ATP5I, NDUFA3, UQCR, NDUFB8, SDHA, NDUFB5, CYC1, UQCRFS1, NDUFS1, COX11, SDHC, NDUFA8, UQCRC1, ATP5O, NDUFS6, PET112L, ATP5G1, MBD3, COX15, ATP5J, NDUFS2, NDUFAB1, COX6C, UQCRC2, ATP5F1, NDUFS3, SURF1, NDUFC1, COX5A, ATP5C1, SDHB, NDUFS7, ATP5D, NDUFA10, COX5B, NDUFA9, COX4I1, UQCRB, COX7A2, NDUFB6, NDUFA4, COX6A1, ATP5G3, COX7C, ATP5B, SDHD
NETPATH IL 2 PATHWAY UPPFKFB3, RAB31, PRF1, PTPN22, AIF1, NMI, TLR4, PMAIP1, ITGAM, FOS, IFNG, KLF13, IFIT1, SP100, IL2RB, IL12RB1, CSF1, TNFSF10, RALB, S100A4, IL10, SLC7A7, LCP2, CD53, FASLG, SERPINE1, CASP1, IL1R1, UPP1, CCR5, BCL2, GBP1, TXK, SLC2A3, SLC1A5, PRKCD, PAK1, SOCS1, CLSPN, IER3, STAT1, STK17B, DUSP5, IRF5, CD69, TRIM21, PRKX, TNFRSF11A, SAMHD1, IL6, PBEF1, SLC7A5, GZMA, MX1, TNF, RGS19, LCK, GNG10, IL18RAP, RBL1, IFI44, FUBP1, GADD45G, CCR2, SRC, RGS1, IL1B, CCL3, ICAM1, IRF1, MYC, SACS, MAPKAPK3, JUN, TNFRSF1B, PSCDBP, SOCS3, TRAFD1, NOS1AP, SLAMF1, CCL4, GZMB, PAX4, KLF6, VIM, WARS, LTB, CCR1, PTPRC, IL2RG, NKG7, MYB, GYPA, DAXX, CTSC, PTGER2, CHSY1, PLAUR
NETPATH IL 4 PATHWAY UPCA2, BCL2L11, XCL1, HPCAL1, TLR4, RASA2, ITGAM, CD86, FOS, IFNG, TFEC, RGS2, IL2RB, IBRDC3, MCM5, MAF, IL10, MCM6, IL10RA, CXCR4, UPP1, FGL2, BCL2, CCL2, VCAM1, NNMT, SOCS1, SAMSN1, ARHGAP25, IL13RA1, STK17B, ANXA1, MXD1, REL, SCGB3A1, RASGRP1, IL6, SATB1, PIK3CG, CH25H, CYP1B1, LOX, TOP2A, AIM1, RIPK2, GNAI1, TNC, EGR2, EDNRA, CEBPB, RBMS1, GAS6, SELE, CSPG2, MYC, SLC38A1, JUN, SOCS3, F13A1, IL1RN, S100A9, GZMB, KLF4, CSF3R, NKG7, CDC25A, PTGER2, CTSC
NETPATH IL 1 PATHWAY UPLCN2, MMP14, BUB1, PRG1, NFKBIA, LOX, IFNG, CXCL2, LCP1, UBD, CXCL1, CCL8, SAA2, IL1A, CHI3L1, SERPINE1, IL1B, ICAM1, MYC, ANXA3, RHOB, JUN, CCL2, NFKBIE, SERPINB2, CCL7, PRKCD, TNFRSF11B, AMPD3, MT2A, CCL4, BIRC3, WARS, CXCL5, IL6, PBEF1
NETPATH B CELL RECEPTOR PATHWAYSYK, VAV1, LCK, PIK3CG, BCL2L11, HCK, PTPN6, NFKBIA, DOK3, ACTR3, DAPP1, PIP5K2A, GAB2, PTPN18, PRKCB1, BAX, SH3BP2, CBL, LCP2, PILRB, FYN, PTK2B, CCNE1, DOK1, BCL2, JUN, CD22, CMTM3, PRKCD, PIK3AP1, CBLB, HCLS1, PLCG2, NEDD9, STAT1, REL, INPP5D, WAS, PTPRC, CD72, LAT2, PLEKHA2, BTK
NETPATH B CELL RECEPTOR PATHWAY UPPSMB8, MAPK7, EREG, TYROBP, CD44, DDIT3, BCL2L11, HCK, AIF1, MYO5A, NMI, CYP1B1, SIPA1, PIP5K2A, CD86, FOS, LAT, TGFB1, EGR2, FLI1, MYD88, IFITM1, CD48, IL6R, IL10, LCP2, NRGN, CCL3, TNFAIP3, ICAM1, MYC, TNFRSF10B, CCNE1, RHOB, CAPZA2, BCL2, JUN, MCL1, CCL2, TXK, TRAF1, CCL5, CD24, UBE2L6, BIRC3, RGS12, IFNGR1, CD69, INPP5D, IFNGR2, CCR1, TNF
NCI AMB2 NEUTROPHILS PATHWAYLCK, THY1, ELA2, PLAT, HCK, ITGAM, GP1BA, MPO, RAP1B, SELP, FGR, TLN1, ITGB2, LAMC3, SRC, FYN, IL6, CTGF, ICAM1, PLAUR, TNF
NCI TXA2PATHWAYSYK, LCK, PIK3CG, HCK, PTGIR, VCAM1, PRKCD, ADRBK2, ADRBK1, GNG2, PRKCH, PRKCB1, FGR, PIK3R5, SELE, ICAM1, ARRB2
NCI EXOCYTOSIS OF ALPHA GRANULE PROS1, GP5, MMRN1, CD9, F13A1, ALDOA, GP1BA, TMSB4X, CD36, GP1BB, PF4, PPBP, SELP, TIMP1, ITGB3, ITGA2B, GP9, SERPINE1, VWF
NETPATH IL 5 PATHWAY UPPLSCR1, TPM4, CD44, TLR4, TLR6, RELB, CASP4, MYD88, EGR2, IL1A, TBK1, LCP2, IL1B, CCL3, SELE, ICAM1, PRDM1, UPP1, CIITA, RHOH, TLR1, BCL2, NFKB2, CCL2, NFKBIE, IL3RA, SLC1A5, CD55, NFE2, CD24, IER3, REL, BIRC3, SELP, DUSP5, SRI, CD69, LTB, HLX1, ITGB2, CCR1, CTSC
NETPATH IL 5 PATHWAYPLA2G4A, SDCBP, SYK, VAV1, JUN, PIK3CG, HCK, PTPN6, NFKBIA, PRKCD, HCLS1, SOCS1, STAT1, IL2RB, PRKCB1, JAK2, CBL, PTK2B, BTK, GRB2
NCI IL2 1PATHWAYSYK, LCK, BCL2, JUN, SOCS3, SOCS1, GAB2, FOS, IFNG, DOK2, STAT1, IL2RB, PRKCB1, JAK3, IL2RG, FYN, MYC, PTK2B
NETPATH IL 3 PATHWAY UPBCL2, MCL1, CCL2, KIT, ANXA2, SOCS3, IL3RA, CCL7, SOCS1, CD86, FOS, TGFB1, CCL4, CSF1, CD69, IL6R, CCR1, CSF2RA, IL1B, CCL3, MYB, MYC, TNF
NETPATH IL 2 PATHWAY DOWNHMHA1, LIMS1, LAPTM5, SELL, PKIA, PTPN22, TBC1D8, PRG1, RBL1, TLR6, ZCCHC11, PTPN6, PSAT1, KLRK1, RGS10, CD52, LAT, EMP3, GZMK, PRKCB1, CD68, IL16, HEMGN, PBXIP1, ELF1, FYB, AHNAK, CRIP1, EHD1, ITGAX, ARRB2, MYC, SPON1, CCNE1, EVI2A, LOH11CR2A, GLS, UCP2, PASK, MYO1F, SOCS3, LSP1, SH2D1A, MT2A, GPR18, SLC7A1, CCL5, EVL, GRK5, RASGRP2, S100A11, ADA, BIRC3, SORL1, LRMP, TAP1, ITGB7, PTPRC, ITGA2B, PSCD4, LY9
NCI IL12 2PATHWAYCCR5, GADD45B, LCK, NFKB2, IL18RAP, SOCS1, FOS, IFNG, RIPK2, RELB, CCL4, GZMB, STAT1, IL2RB, IL12RB1, JAK2, EOMES, GADD45G, TBX21, CD3G, IL2RG, FASLG, CCL3, IL1B, IL1R1, GZMA
NETPATH IL 4 PATHWAY DOWNLTB4R, GADD45B, CD9, CCL2, KIT, TLR4, NFKBIA, CYSLTR2, ALOX5AP, CXCL2, ITGA2, PDGFB, STAT1, UBE2L6, TIMP1, VIM, LTB, FCER1G, TNFSF10, GBP2, CHI3L1, TLR3, IL6, GEM, ICAM1, MFNG, IRF1, TLR2, TNF, MX1, GZMA
NCI CXCR4 PATHWAYRHOB, VAV1, LCK, PIK3CG, HCK, PTPN6, PAK1, ADRBK1, ITGA2, GNAI1, GNG2, STAT1, RAP1B, JAK2, FGR, RALB, PTPRC, CD3G, GRK6, SRC, PIK3R5, RGS1, FYN, RHOC, GNAZ, ARRB2, ITGA9, CXCR4, PTK2B
NETPATH B CELL RECEPTOR PATHWAY DOWNRAB31, LCK, NFKBIA, ISG20, ACTA2, SLA, CXCL1, TNFSF10, ABR, GBP2, FYN, IFRD1, SELE, FRZB, IRF1, MYC, CXCR4, NCF4, EVI2A, CD22, CD40, TNFRSF1B, CERKL, PRKCD, HCLS1, RAC2, PRKAR2B, ADAM8, GRK5, PLCG2, PF4, MYBL2, DUSP5, ARHGEF2, P2RY6, CD3G, PTPRC, DUSP2, GNAZ, IRF7, GZMA, BTK
NETPATH T CELL RECEPTOR PATHWAYABI1, ARHGEF6, SYK, LCK, MAPK7, PTPN22, PTPN6, GAB2, PTPN12, LAT, RIPK2, PSTPIP1, SLA, WASF2, CEBPB, SH3BP2, CBL, FYB, LCP2, FYN, PTK2B, CD2AP, WASPIP, JUN, CD22, CD40, TXK, CBLB, PAK1, EVL, RASGRP2, GRAP, NEDD9, STAT1, JAK3, WAS, CD3G, PTPRC, NFAM1, DEF6, ARHGDIB
NETPATH IL 6 PATHWAY UPPROS1, ABCC4, GADD45B, JUN, MCL1, CD44, LOH11CR2A, MAP3K8, NMI, SLC2A3, SOCS3, TNFRSF11B, SOCS1, FOS, SBNO2, STAT1, CXCL1, CEBPD, ABCC1, JUNB, CEBPB, NEU3, SAA2, PDGFRA, POU2F2, MAFF, IRF1, PRDM1, MX1, TNF
NETPATH KIT RECEPTOR PATHWAYDOK1, VAV1, KIT, PIK3CG, SPRED1, FES, HCK, PTPN6, SOCS1, GRAP, STAT1, PRKCB1, JAK2, INPP5D, FGR, CBL, SRC, FYN, SH3KBP1, KITLG, BTK, GRB2
GERY CEBP TARGETSLCN2, TRIB3, EREG, DDIT3, PLAT, SLFN4, IFI203 /// IFI204 //, FOS, SAT1, MKNK2, BTG2, LYZS, RGS2, ACTA2, CD68, CXCL1, XDH, JUNB, GADD45G, IFI204 /// LOC672547, IFRD1, CSPG2, GADD45B, SLFN2, SERPINB2, PROCR, GLA, CD47, DBP, MAFK, GIPC2, HMOX1, CYB5R1, KLF4, S100A8, CXCL5, ATF3, SAA3P, TGTP, PLAUR
NETPATH IL 7 PATHWAY UPBCL2, JUN, MCL1, CD44, KLRK1, CCL19, CCL5, CXCL2, CD86, CCL4, PPBP, CXCL1, IGLL1, CCL8, CXCL5, FIGF, FAS, CCL3, CXCR4, MYC
NCI IL27PATHWAYSTAT1, IL12B, IL12RB1, IL18, JAK2, TBX21, IL6, IL1B, IFNG, TGFB1, EBI3, TNF
NETPATH IL 4 PATHWAYLCK, CD40, FES, NCF1, SOCS3, PTPN6, PRKCD, ADRBK2, SOCS1, DOK2, STAT1, JAK2, JAK3, INPP5D, SRC, IL2RG, FYN, CXCR4, SPI1
NCI IL23PATHWAYSTAT1, JAK2, IL12RB1, CXCL1, CCL2, IL18RAP, SOCS3, NFKBIA, IL6, IL1B, CXCL9, IFNG, MPO, TNF
SA MMP CYTOKINE CONNECTIONSPN, CSF1, CD44, IL6R, SELL, TNFRSF1B, FCGR3A, TNFRSF1A, IL1B, TGFB1, TNF
NCI TCR PATHWAYVAV1, LCK, MAP3K8, CD80, PTPN6, GAB2, LAT, CD86, PRKCQ, FLNA, PRKCB1, WAS, SH3BP2, MALT1, FYB, CD3G, PTPRC, CBL, LCP2, CD28, RASSF5, FYN, GRB2
NETPATH T CELL RECEPTOR PATHWAY DOWNARG2, CCR5, JUN, CHST11, NFKBIA, LSP1, TOP2A, TGFB1, IL10RB, IFITM1, ANXA1, FCER1G, CCR1, FYB, CCR2, CASP1, IRF7, TNF, ARHGDIB
NCI CD8TCRPATHWAYVAV1, LCK, PRF1, MAP3K8, CD80, PTPN6, LAT, CD86, PRKCQ, PRKCB1, MALT1, CBL, CD3G, PTPRC, LCP2, RASSF5, CD28, FYN, GRB2
NCI PI3KCIPATHWAYARHGEF6, CENTA1, SYK, VAV1, LCK, PIK3CG, HCK, DAPP1, LAT, PLCG2, PSCD1, FGR, SRC, PIK3R5, FYN, BTK, PLEKHA2
NCI IL6 7PATHWAYVAV1, JUN, MCL1, HCK, SOCS3, PRKCD, GAB2, FOS, STAT1, TIMP1, CEBPD, JAK2, CEBPB, IL6R, JUNB, LBP, LMO4, IL6, IRF1, MYC, PTPRE
NCI CELL SURFACE INTERACTIONS AT THE VASCULAR WALLCD48, CD84, FCER1G, THBD, ITGB2, MERTK, FYN, ITGAM, ITGAX, ITGA4
NCI IL4 2PATHWAYTHY1, FES, SOCS3, PTPN6, SOCS1, COL1A1, DOK2, IL13RA1, EGR2, SELP, PARP14, JAK2, JAK3, CEBPB, CBL, IL10, ITGB3, IL2RG, MYB, SPI1
NCI IL12 STAT4PATHWAYPRF1, JUN, IL18RAP, TBX21, CD80, CD3G, CD28, IRF1, TGFB1, CD86, FOS, IFNG
ST TUMOR NECROSIS FACTOR PATHWAYMAP3K3, NFKBIB, BIRC3, JUN, NFKB2, NFKBIE, BIRC2, TNFRSF1B, NFKBIA, TNFRSF1A, TNFAIP3, TNF
NCI IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELLVCAM1, IFITM1, KLRD1, KLRK1, TYROBP, SELL, CD40, ITGB2, ITGB7, ITGA4
ST STAT3 PATHWAYSRC, IL6, JAK2, JAK3, IL6R
NETPATH IL 9 PATHWAY UPLCN2, CCL2, JUNB, SELL, SOCS3, CCL7, CCL3, MYC, GZMA, GZMB
NCI INTEGRIN ALPHAIIBBETA3 SIGNALINGITGB3, PTPN1, SRC, ITGA2B, TLN1
CORUM ITGA2B-ITGB3-CD9-GP1B-CD47 COMPLEXGP1BB, ITGB3, ITGA2B, CD9, GP1BA, CD47
ST T CELL SIGNAL TRANSDUCTIONNFKBIB, VAV1, LCK, RASGRP4, NFKB2, NFKBIE, NFKBIA, PAK1, LAT, RASGRP2, RASGRP1, CBL, PTPRC, LCP2, CD28, GRB2
RICKMAN METASTASIS DN
NCI COLLAGEN ADHESION VIA ALPHA 2 BETA 1 GLYCOPROTEIN
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION GRANULOCYTE DN
BIOCARTA IL10 PATHWAY
ITO PTTG1 TARGETS UP
RASHI RESPONSE TO IONIZING RADIATION 6
BIOCARTA RHO PATHWAY
MAHAJAN RESPONSE TO IL1A UP
WEINMANN ADAPTATION TO HYPOXIA DN
CORUM ITGA2B-ITGB3-CD9 COMPLEX
CORUM BRCA1-LMO4-CTIP COMPLEX
FAELT B CLL WITH VH REARRANGEMENTS UP
LINDSTEDT DENDRITIC CELL MATURATION B
BIOCARTA IL1R PATHWAY
REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS
HUANG FOXA2 TARGETS DN
RADAEVA RESPONSE TO IFNA1 UP
LUI THYROID CANCER CLUSTER 4
NCI A4B1 A4B7 PATHWAY
COATES MACROPHAGE M1 VS M2 UP
BOWIE RESPONSE TO EXTRACELLULAR MATRIX
MISHRA CARCINOMA ASSOCIATED FIBROBLAST UP
BIOCARTA THELPER PATHWAY
CORUM MCL1-NOXA COMPLEX
MUNSHI MULTIPLE MYELOMA UP
WANG SMARCE1 TARGETS UP
AMIT EGF RESPONSE 480 HELA
JEON SMAD6 TARGETS UP
SARRIO EPITHELIAL MESENCHYMAL TRANSITION DN
LIN SILENCED BY TUMOR MICROENVIRONMENT
NCI GENERATION OF SECOND MESSENGER MOLECULES
HASINA NOL7 TARGETS UP
KLEIN PRIMARY EFFUSION LYMPHOMA DN
ALCALA APOPTOSIS
BIOCARTA MCM PATHWAY
REACTOME E2F TRANSCRIPTIONAL TARGETS AT G1 S
LENAOUR DENDRITIC CELL MATURATION DN
BOYAULT LIVER CANCER SUBCLASS G56 DN
KUMAR TARGETS OF MLL AF9 FUSION
CORUM ITGA9-ITGB1-VCAM1 COMPLEX
KOKKINAKIS METHIONINE DEPRIVATION 96HR UP
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 6HR UP
KANG DOXORUBICIN RESISTANCE UP
LI CYTIDINE ANALOG PATHWAY
COULOUARN TEMPORAL TGFB1 SIGNATURE UP
PAL PRMT5 TARGETS DN
SENGUPTA EBNA1 ANTICORRELATED
CERVERA SDHB TARGETS 1 UP
NAKAMURA METASTASIS
CORUM PRB2/P130-MULTIMOLECULAR COMPLEX RB2 E2F5 HDAC1 SUV39H1 P300
NIELSEN SYNOVIAL SARCOMA DN
REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES
SEITZ NEOPLASTIC TRANSFORMATION BY 8P DELETION UP
CORUM CHROMOSOMAL PASSENGER COMPLEX CPC INCENP BIRC5 AURKB
SENGUPTA NASOPHARYNGEAL CARCINOMA UP
AMIT EGF RESPONSE 120 HELA
FULCHER INFLAMMATORY RESPONSE LECTIN VS LPS UP
REACTOME APOPTOSIS
KEGG PATHOGENIC ESCHERICHIA COLI INFECTION
MCLACHLAN DENTAL CARIES UP
REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE
GAJATE RESPONSE TO TRABECTEDIN UP
KYNG DNA DAMAGE BY UV
BEGUM TARGETS OF PAX3 FOXO1 FUSION DN
CORUM CHROMOSOMAL PASSENGER COMPLEX CPC INCENP CDCA8 BIRC5 AURKB
BIOCARTA TCR PATHWAY
CORUM PLC-GAMMA-2-LAT COMPLEX
HELLER SILENCED BY METHYLATION UP
KEGG CELL ADHESION MOLECULES CAMS
CORUM CBL-SLP-76-GRB2 COMPLEX FC RECEPTOR GAMMA-R1 STIMULATED
GOZGIT ESR1 TARGETS DN
LAU APOPTOSIS CDKN2A UP
NCI P38ALPHABETAPATHWAY
BIOCARTA MONOCYTE PATHWAY
MOOTHA FFA OXYDATION
SMID BREAST CANCER LUMINAL B DN
LEE LIVER CANCER CIPROFIBRATE UP
BERENJENO TRANSFORMED BY RHOA UP
CORUM ITGA4-ITGB1-CD53 COMPLEX
CORUM ITGAV-ITGB8-MMP14-TGFB1 COMPLEX
CORUM REL-MAP3K8-RELA-TNIP2-PAPOLA COMPLEX
REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL
MARSON FOXP3 TARGETS STIMULATED UP
BIOCARTA IL17 PATHWAY
CORUM ARP2/3 PROTEIN COMPLEX
VERHAAK AML WITH NPM1 MUTATED UP
AMIT EGF RESPONSE 40 MCF10A
REACTOME GENERATION OF SECOND MESSENGER MOLECULES
REACTOME G ALPHA I SIGNALLING EVENTS
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION HSC DN
NCI ACTIVATION MYRISTOLYATION OF BID AND TRANSLOCATION TO MITOCHONDRIA
SPIRA SMOKERS LUNG CANCER UP
CORUM IKBEPSILON-RELA-CREL COMPLEX
ROSS ACUTE MYELOID LEUKEMIA CBF
CHASSOT SKIN WOUND
TIAN TNF SIGNALING VIA NFKB
KEGG TOLL LIKE RECEPTOR SIGNALING PATHWAY
GOLUB ALL VS AML DN
KEGG APOPTOSIS
CORUM NFKB1-NFKB2-REL-RELA-RELB COMPLEX
CORUM 13S CONDENSIN COMPLEX
ZHAN MULTIPLE MYELOMA MF UP
CHIANG LIVER CANCER SUBCLASS CTNNB1 DN
HOSHIDA LIVER CANCER SURVIVAL UP
CHARAFE BREAST CANCER LUMINAL VS BASAL DN
MISSIAGLIA REGULATED BY METHYLATION UP
NCI CLASSICAL ANTIBODY MEDIATED COMPLEMENT ACTIVATION
CHIARADONNA NEOPLASTIC TRANSFORMATION CDC25 DN
NCI ATF2 PATHWAY
ZHAN MULTIPLE MYELOMA CD1 AND CD2 DN
GEORGANTAS HSC MARKERS
RHODES UNDIFFERENTIATED CANCER
CORUM BLOC-2 BIOGENESIS OF LYSOSOME-RELATED ORGANELLES COMPLEX 2
KONDO PROSTATE CANCER WITH H3K27ME3
REACTOME SEMAPHORIN INTERACTIONS
KEGG ASTHMA
BOYLAN MULTIPLE MYELOMA D DN
KIM LRRC3B TARGETS
KRIGE RESPONSE TO TOSEDOSTAT 24HR UP
DACOSTA ERCC3 ALLELE XPCS VS TTD UP
BIOCARTA UCALPAIN PATHWAY
WOO LIVER CANCER RECURRENCE DN
REACTOME INTEGRIN CELL SURFACE INTERACTIONS
RUTELLA RESPONSE TO CSF2RB AND IL4 DN
VERNELL RETINOBLASTOMA PATHWAY UP
MULLIGHAN MLL SIGNATURE 2 UP
CHIARADONNA NEOPLASTIC TRANSFORMATION KRAS CDC25 DN
CORUM ERG-JUN-FOS DNA-PROTEIN COMPLEX
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS BLACK UP
SCHAVOLT TARGETS OF TP53 AND TP63
DEBIASI APOPTOSIS BY REOVIRUS INFECTION UP
NETPATH IL 6 PATHWAY
BIOCARTA CYTOKINE PATHWAY
SEIKE LUNG CANCER POOR SURVIVAL
AMIT EGF RESPONSE 20 HELA
GALI TP53 TARGETS APOPTOTIC UP
NCI GLYPICAN 1PATHWAY
NETPATH IL 3 PATHWAY
CORUM BRCA1-IRIS-PRE-REPLICATION COMPLEX
NCI COLLAGEN ADHESION VIA GP IV
BLALOCK ALZHEIMERS DISEASE INCIPIENT UP
CORUM CIN85-CBL-SH3GL2 COMPLEX
MARZEC IL2 SIGNALING UP
BIOCARTA BLYMPHOCYTE PATHWAY
FONTAINE THYROID TUMOR UNCERTAIN MALIGNANCY DN
LINDGREN BLADDER CANCER CLUSTER 2A DN
BOYLAN MULTIPLE MYELOMA C D DN
VERRECCHIA RESPONSE TO TGFB1 C2
CROMER TUMORIGENESIS UP
FRIDMAN SENESCENCE UP
WU HBX TARGETS 2 DN
CORUM SNX COMPLEX SNX11A24 PDGF RECEPTOR
MAHADEVAN RESPONSE TO MP470 UP
FERRARI RESPONSE TO FENRETINIDE UP
KEGG PANCREATIC CANCER
DACOSTA LOW DOSE UV RESPONSE VIA ERCC3 XPCS UP
BIOCARTA TID PATHWAY
AMUNDSON POOR SURVIVAL AFTER GAMMA RADIATION 2G
AMUNDSON POOR SURVIVAL AFTER GAMMA RADIATION 8G
SANA RESPONSE TO IFNG UP
CASTELLANO NRAS TARGETS DN
CHIARADONNA NEOPLASTIC TRANSFORMATION KRAS DN
OHASHI AURKB TARGETS
NCI ENDOTHELINPATHWAY
ELVIDGE HIF2A TARGETS UP
BOYLAN MULTIPLE MYELOMA PCA1 UP
WU HBX TARGETS 1 UP
WANG BARRETTS ESOPHAGUS DN
NCI ALPHASYNUCLEIN PATHWAY
GNATENKO PLATELET SIGNATURE
DASU IL6 SIGNALING SCAR DN
HOEBEKE LYMPHOID STEM CELL UP
CORUM ITGAV-ITGB3-ADAM15 COMPLEX
KEGG PROPANOATE METABOLISM
LU TUMOR ENDOTHELIAL MARKERS DN
MOOTHA MITOCHONDRIA
NCI E2F TRANSCRIPTIONAL TARGETS AT G1 S
REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS
SIG PIP3 SIGNALING IN B LYMPHOCYTES
MOSERLE IFNA RESPONSE
MULLIGHAN MLL SIGNATURE 1 UP
HOLLMAN APOPTOSIS VIA CD40 DN
RODWELL AGING KIDNEY UP
REACTOME TOLL RECEPTOR CASCADES
BREDEMEYER RAG SIGNALING VIA ATM NOT VIA NFKB UP
ODONNELL TARGETS OF MYC AND TFRC UP
GRAHAM CML QUIESCENT VS CML DIVIDING DN
KENNY CTNNB1 TARGETS UP
NCI A4B1 PAXDEP PATHWAY
CROONQUIST IL6 DEPRIVATION DN
BIOCARTA IL7 PATHWAY
CHIANG LIVER CANCER SUBCLASS PROLIFERATION UP
BIOCARTA GRANULOCYTES PATHWAY
LINDSTEDT DENDRITIC CELL MATURATION C
OSMAN BLADDER CANCER UP
VALK AML CLUSTER 5
MORI IMMATURE B LYMPHOCYTE UP
REACTOME ACTIVATED TLR4 SIGNALLING
HUTTMANN B CLL POOR SURVIVAL UP
ELVIDGE HYPOXIA BY DMOG UP
BIOCARTA TOLL PATHWAY
BROWNE HCMV INFECTION 48HR UP
BIOCARTA IL2RB PATHWAY
NCI PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS
REACTOME CELLEXTRACELLULAR MATRIX INTERACTIONS
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL DN
PUJANA BREAST CANCER WITH BRCA1 MUTATED UP
CORUM PLC-GAMMA-2-SLP-76 COMPLEX
VERRECCHIA EARLY RESPONSE TO TGFB1
NCI ACTIVATION OF PRO CASPASE 8
CHEOK RESPONSE TO HD MTX UP
CORUM ETS2-FOS-JUN COMPLEX
PICCALUGA ANGIOIMMUNOBLASTIC LYMPHOMA DN
ELVIDGE HIF1A TARGETS DN
MORI SMALL PRE BII LYMPHOCYTE UP
GRAHAM CML QUIESCENT VS NORMAL DIVIDING DN
CORUM IL6ST-PRKCD-STAT3 COMPLEX
KUNINGER IGF1 VS PDGFB TARGETS DN
LI CISPLATIN RESISTANCE DN
BORCZUK MALIGNANT MESOTHELIOMA DN
MONTERO THYROID CANCER POOR SURVIVAL UP
BIOCARTA TOB1 PATHWAY
HAHTOLA SEZARY SYNDROM DN
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 16D UP
REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS
THEILGAARD NEUTROPHIL AT SKIN WOUND DN
ICHIBA GRAFT VERSUS HOST DISEASE D7 UP
KOYAMA SEMA3B TARGETS UP
ZHU CMV 24 HR UP
GRAHAM NORMAL QUIESCENT VS NORMAL DIVIDING DN
MUELLER COMMON TARGETS OF AML FUSIONS DN
REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA
CHEN LVAD SUPPORT OF FAILING HEART UP
HELLER HDAC TARGETS SILENCED BY METHYLATION DN
THUM MIR21 TARGETS HEART DISEASE UP
MCBRYAN PUBERTAL BREAST 4 5WK UP
CORUM ITGA2B-ITGB3-F11R COMPLEX
MORI LARGE PRE BII LYMPHOCYTE DN
YAGI AML FAB MARKERS
NETPATH TGFBETA RECEPTOR PATHWAY UP
CHIANG LIVER CANCER SUBCLASS PROLIFERATION DN
KYNG DNA DAMAGE BY 4NQO
BIOCARTA NKT PATHWAY
NCI IL2 STAT5PATHWAY
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 5
CORUM ITGA2B-ITGB3 COMPLEX
MORI EMU MYC LYMPHOMA BY ONSET TIME DN
RODRIGUES DCC TARGETS UP
BROWNE INTERFERON RESPONSIVE GENES
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 8D DN
WILENSKY RESPONSE TO DARAPLADIB
PASQUALUCCI LYMPHOMA BY GC STAGE DN
REACTOME SIGNALING IN IMMUNE SYSTEM
ROETH TERT TARGETS UP
BIOCARTA LAIR PATHWAY
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION SUSTAINDED IN ERYTHROCYTE UP
LE EGR2 TARGETS UP
AKL HTLV1 INFECTION DN
RICKMAN HEAD AND NECK CANCER D
DAZARD UV RESPONSE CLUSTER G3
IIZUKA LIVER CANCER PROGRESSION L0 L1 DN
CHIARADONNA NEOPLASTIC TRANSFORMATION KRAS CDC25 UP
OSADA ASCL1 TARGETS DN
BIOCARTA LYM PATHWAY
NUYTTEN EZH2 TARGETS UP
DUTTA APOPTOSIS VIA NFKB
CHUNG BLISTER CYTOTOXICITY DN
CORUM ITGAV-ITGB3-CD47-FCER2 COMPLEX
DER IFN GAMMA RESPONSE UP
MCMURRAY TP53 HRAS COOPERATION RESPONSE UP
REACTOME PROSTANOID HORMONES
KANG CISPLATIN RESISTANCE UP
RUTELLA RESPONSE TO HGF VS CSF2RB AND IL4 UP
ZHOU INFLAMMATORY RESPONSE LIVE UP
BIOCARTA ERYTH PATHWAY
NIELSEN MALIGNAT FIBROUS HISTIOCYTOMA UP
HENDRICKS SMARCA4 TARGETS DN
NEWMAN ERCC6 TARGETS UP
CORUM TNF-ALPHA/NF-KAPPA B SIGNALING COMPLEX CHUK KPNA3 NFKB2 NFKBIB REL IKBKG NFKB1 NFKBIE RELB NFKBIA RELA TNIP2
HEIDENBLAD AMPLICON 12P11 12 DN
REACTOME TOLL LIKE RECEPTOR 9 CASCADE
XU CREBBP TARGETS DN
RAMALHO STEMNESS DN
FOSTER INFLAMMATORY RESPONSE LPS DN
REACTOME BASIGIN INTERACTIONS
FINETTI BREAST CANCER KINOME GREEN
GAURNIER PSMD4 TARGETS
CORUM TGF-BETA RECEPTOR II-TGF-BETA RECEPTOR I-TGF-BETA1 COMPLEX
FARMER BREAST CANCER CLUSTER 1
GRANDVAUX IFN RESPONSE NOT VIA IRF3
BIOCARTA HIVNEF PATHWAY
SATO SILENCED BY DEACETYLATION IN PANCREATIC CANCER
CLAUS PGR POSITIVE MENINGIOMA DN
MARKEY RB1 CHRONIC LOF DN
CORUM CIN85-SH3GL2 COMPLEX
NCI CD8TCRDOWNSTREAMPATHWAY
REACTOME FORMATION OF PLATELET PLUG
GESERICK TERT TARGETS DN
REACTOME PLATELET DEGRANULATION
STEIN ESRRA TARGETS RESPONSIVE TO ESTROGEN DN
AMIT SERUM RESPONSE 120 MCF10A
BIOCARTA SRCRPTP PATHWAY
APPEL IMATINIB RESPONSE
BOYLAN MULTIPLE MYELOMA D CLUSTER DN
MARTORIATI MDM4 TARGETS NEUROEPITHELIUM DN
LEE LIVER CANCER MYC E2F1 UP
BASSO HAIRY CELL LEUKEMIA DN
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION SUSTAINED IN MONOCYTE DN
GEISS RESPONSE TO DSRNA UP
SATO SILENCED BY METHYLATION IN PANCREATIC CANCER 1
CORUM LCK-SLP76-PLC-GAMMA-1-LAT COMPLEX PERVANADATE-ACTIVATED
BOYLAN MULTIPLE MYELOMA C CLUSTER DN
ZHOU INFLAMMATORY RESPONSE FIMA UP
HAHTOLA CTCL PATHOGENESIS
REACTOME GPCR LIGAND BINDING
GRUETZMANN PANCREATIC CANCER UP
OKUMURA INFLAMMATORY RESPONSE LPS
BIOCARTA ACH PATHWAY
NATSUME RESPONSE TO INTERFERON BETA UP
VALK AML WITH CEBPA
BIOCARTA CASPASE PATHWAY
BENPORATH PROLIFERATION
AMIT EGF RESPONSE 60 MCF10A
TSUNODA CISPLATIN RESISTANCE UP
KEGG CYTOKINE CYTOKINE RECEPTOR INTERACTION
CHEN HOXA5 TARGETS 6HR UP
SMIRNOV CIRCULATING ENDOTHELIOCYTES IN CANCER UP
NCI G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA
RODWELL AGING KIDNEY NO BLOOD UP
BIOCARTA FAS PATHWAY
LEONARD HYPOXIA
REACTOME SIGNAL AMPLIFICATION
ROSS AML WITH MLL FUSIONS
MMS MOUSE LYMPH HIGH 4HRS UP
GOZGIT ESR1 TARGETS UP
CHEN LVAD SUPPORT OF FAILING HEART DN
CORUM ITGA2B-ITGB3-CD47-FAK COMPLEX
FONTAINE PAPILLARY THYROID CARCINOMA DN
CHENG RESPONSE TO NICKEL ACETATE
REACTOME DOWNSTREAM EVENTS IN GPCR SIGNALING
NCI TOLL LIKE RECEPTOR 4 TLR4 CASCADECD180, LY96, CD14, LBP, LY86, TLR4
WU CELL MIGRATION
WALLACE PROSTATE CANCER RACE UP
BIOCARTA CCR5 PATHWAY
BASAKI YBX1 TARGETS UP
KEGG ECM RECEPTOR INTERACTION
KEGG MAPK SIGNALING PATHWAY
SHIPP DLBCL VS FOLLICULAR LYMPHOMA DN
ONDER CDH1 SIGNALING VIA CTNNB1
GUTIERREZ WALDENSTROEMS MACROGLOBULINEMIA 1 DN
REACTOME COLLAGEN MEDIATED ACTIVATION CASCADE
ZHONG RESPONSE TO AZACITIDINE AND TSA UP
AMUNDSON GENOTOXIC SIGNATURE
CONCANNON APOPTOSIS BY EPOXOMICIN DN
BIOCARTA IL12 PATHWAY
EHRLICH ICF SYNDROM DN
UROSEVIC RESPONSE TO IMIQUIMOD
BROWNE HCMV INFECTION 30MIN UP
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 3D UP
FULCHER INFLAMMATORY RESPONSE LECTIN VS LPS DN
CASORELLI ACUTE PROMYELOCYTIC LEUKEMIA UP
KOKKINAKIS METHIONINE DEPRIVATION 48HR UP
MORI SMALL PRE BII LYMPHOCYTE DN
SANA TNF SIGNALING DN
REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL
REACTOME INNATE IMMUNITY SIGNALING
REACTOME HEMOSTASIS
SWEET LUNG CANCER KRAS DN
XU RESPONSE TO TRETINOIN AND NSC682994 UP
LAIHO COLORECTAL CANCER SERRATED UP
BIOCARTA DC PATHWAY
ST JAK STAT PATHWAY
ROY WOUND BLOOD VESSEL UP
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 6HR DN
CORUM IL4-IL4R-IL2RG COMPLEX
CORUM ITGB3-ITGAV-CD47 COMPLEX
CORUM ITGA4-ITGB1-EMILIN1 COMPLEX
CORUM ITGA2B-ITGB3-CD47-SRC COMPLEX
WATANABE COLON CANCER MSI VS MSS UP
REACTOME P2Y RECEPTORS
REACTOME G ALPHA 12 13 SIGNALLING EVENTS
CORUM ELMO1-DOCK2 COMPLEX
GOLDRATH ANTIGEN RESPONSE
BIOCARTA TCRA PATHWAY
BILD HRAS ONCOGENIC SIGNATURE
FLECHNER PBL KIDNEY TRANSPLANT OK VS DONOR DN
DAUER STAT3 TARGETS UP
LIANG SILENCED BY METHYLATION 2
RIGGI EWING SARCOMA PROGENITOR DN
WU HBX TARGETS 3 DN
DER IFN ALPHA RESPONSE UP
KEGG DILATED CARDIOMYOPATHY
REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION
GRABARCZYK BCL11B TARGETS UP
CROONQUIST IL6 DEPRIVATION UP
BERENJENO TRANSFORMED BY RHOA FOREVER DN
AMIT EGF RESPONSE 60 HELA
ADDYA ERYTHROID DIFFERENTIATION BY HEMIN
NCI P2Y RECEPTORS
DAZARD UV RESPONSE CLUSTER G2
MARKS HDAC TARGETS DN
NCI CD40 PATHWAY
MCLACHLAN DENTAL CARIES DN
KEGG ALLOGRAFT REJECTION
ZHANG RESPONSE TO IKK INHIBITOR AND TNF UP
BIOCARTA INFLAM PATHWAY
SANA TNF SIGNALING UP
THUM SYSTOLIC HEART FAILURE UP
SENESE HDAC1 AND HDAC2 TARGETS UP
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 3D DN
ROSS AML WITH CBFB MYH11 FUSION
NAKAJIMA MAST CELL
BASSO CD40 SIGNALING DN
MANALO HYPOXIA UP
CASTELLANO NRAS TARGETS UP
GRAHAM CML QUIESCENT VS NORMAL QUIESCENT UP
HAHTOLA MYCOSIS FUNGOIDES CD4 UP
KEGG HEMATOPOIETIC CELL LINEAGE
LEE TARGETS OF PTCH1 AND SUFU DN
SATO SILENCED BY METHYLATION IN PANCREATIC CANCER 2
HOFFMANN LARGE TO SMALL PRE BII LYMPHOCYTE DN
NCI TOLL LIKE RECEPTOR TLR6 TLR2 CASCADE
VECCHI GASTRIC CANCER ADVANCED VS EARLY UP
KLEIN TARGETS OF BCR ABL1 FUSION
CORUM ITGAV-ITGB3-PXN-PTK2B COMPLEX
UZONYI RESPONSE TO LEUKOTRIENE AND THROMBIN
BIOCARTA KERATINOCYTE PATHWAY
BAELDE DIABETIC NEPHROPATHY DN
CORUM LMO4-BRCA1-CTIP-LDB1 COMPLEX
CHIARADONNA NEOPLASTIC TRANSFORMATION KRAS UP
CHIANG LIVER CANCER SUBCLASS INTERFERON UP
REACTOME PLATELET ACTIVATION TRIGGERS
KALMA E2F1 TARGETS
NETPATH T CELL RECEPTOR PATHWAY UP
HELLER HDAC TARGETS DN
CROONQUIST NRAS VS STROMAL STIMULATION DN
GRAHAM CML QUIESCENT VS NORMAL DIVIDING UP
BOHN PRIMARY IMMUNODEFICIENCY SYNDROM DN
GOUYER TATI TARGETS UP
ZHAN MULTIPLE MYELOMA HP UP
NCI GLUCOSE ATP GLUCOSE 6 PHOSPHATE ADP
NCI LPS TRANSFERRED FROM LBP CARRIER TO CD14
NCI PDGFRBPATHWAY
LU IL4 SIGNALING
NUNODA RESPONSE TO DASATINIB IMATINIB DN
IVANOVA HEMATOPOIESIS MATURE CELL
WATTEL AUTONOMOUS THYROID ADENOMA DN
YAMASHITA METHYLATED IN PROSTATE CANCER
NCI VWF INTERACTION WITH COLLAGEN
KEGG CITRATE CYCLE TCA CYCLE
NCI BCR 5PATHWAY
GRAHAM NORMAL QUIESCENT VS NORMAL DIVIDING UP
BIOCARTA NFKB PATHWAY
LINDGREN BLADDER CANCER CLUSTER 2B
KEGG GRAFT VERSUS HOST DISEASE
NIELSEN LEIOMYOSARCOMA UP
VARELA ZMPSTE24 TARGETS UP
REACTOME PEPTIDE LIGAND BINDING RECEPTORS
NCI TNFPATHWAY
CHEN HOXA5 TARGETS 6HR DN
KRASNOSELSKAYA ILF3 TARGETS UP
RASHI RESPONSE TO IONIZING RADIATION 2
NCI GPVI MEDIATED ACTIVATION CASCADE
CORUM CDC2-PCNA-CCNB1-GADD45B COMPLEX
LIEN BREAST CARCINOMA METAPLASTIC VS DUCTAL UP
DACOSTA LOW DOSE UV RESPONSE VIA ERCC3 XPCS DN
KEGG HYPERTROPHIC CARDIOMYOPATHY HCM
GRAHAM CML QUIESCENT VS NORMAL QUIESCENT DN
YAGI AML WITH T 8 21 TRANSLOCATION
LINDSTEDT DENDRITIC CELL MATURATION D
VALK AML CLUSTER 1
AMIT EGF RESPONSE 40 HELA
ZHAN EARLY DIFFERENTIATION GENES DN
CHAUHAN RESPONSE TO METHOXYESTRADIOL DN
MITSIADES RESPONSE TO APLIDIN UP
MORI MATURE B LYMPHOCYTE UP
THEILGAARD NEUTROPHIL AT SKIN WOUND UP
XU CREBBP TARGETS UP
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION ERYTHROCYTE UP
MARTORIATI MDM4 TARGETS FETAL LIVER UP
ZHU CMV 24 HR DN
KEGG FOCAL ADHESION
HINATA NFKB TARGETS KERATINOCYTE UP
MILICIC FAMILIAL ADENOMATOUS POLYPOSIS DN
RUTELLA RESPONSE TO CSF2RB AND IL4 UP
CORUM CD20-LCK-LYN-FYN-P75/80 COMPLEX RAJI HUMAN B CELL LINE
MARKEY RB1 ACUTE LOF UP
NCI FRUCTOSE 6 PHOSPHATE AND ATP REACT TO FORM FRUCTOSE 2 6 BISPHOSPHATE AND ADP
REN ALVEOLAR RHABDOMYOSARCOMA DN
SARRIO EPITHELIAL MESENCHYMAL TRANSITION UP
XU AKT1 TARGETS 6HR
REACTOME INTRINSIC PATHWAY FOR APOPTOSIS
LIANG HEMATOPOIESIS STEM CELL NUMBER SMALL VS HUGE DN
HUANG FOXA2 TARGETS UP
NCI MYC REPRESSPATHWAY
POOLA INVASIVE BREAST CANCER UP
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 16D DN
ZHAN LATE DIFFERENTIATION GENES DN
RICKMAN TUMOR DIFFERENTIATED WELL VS POORLY DN
LIU VAV3 PROSTATE CARCINOGENESIS UP
CORUM SH3P2/OSTF1-CBL-SRC COMPLEX
KORKOLA TERATOMA
SHIPP DLBCL VS FOLLICULAR LYMPHOMA UP
CASTELLANO HRAS TARGETS DN
DAUER STAT3 TARGETS DN
REACTOME PURINE SALVAGE REACTIONS
RUTELLA RESPONSE TO HGF VS CSF2RB AND IL4 DN
WU APOPTOSIS BY CDKN1A VIA TP53
KEGG PEROXISOME
CORUM ITGAM-ITGB2-CD11 COMPLEX
DANG REGULATED BY MYC DN
NCI CHEMOKINE RECEPTORS BIND CHEMOKINES
CHEBOTAEV GR TARGETS DN
NCI GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS
PARK TRETINOIN RESPONSE
REACTOME ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 12
ZHANG BREAST CANCER PROGENITORS DN
RUGO RESPONSE TO 4NQO
IIZUKA LIVER CANCER PROGRESSION G1 G2 UP
PODAR RESPONSE TO ADAPHOSTIN UP
JAATINEN HEMATOPOIETIC STEM CELL DN
HOSHIDA LIVER CANCER SUBCLASS S1
DIRMEIER LMP1 RESPONSE LATE DN
KYNG DNA DAMAGE UP
LEE LIVER CANCER E2F1 UP
LIANG HEMATOPOIESIS STEM CELL NUMBER LARGE VS TINY UP
DAVIES MULTIPLE MYELOMA VS MGUS DN
PARK TRETINOIN RESPONSE AND RARA PLZF FUSION
WANG SMARCE1 TARGETS DN
KEGG FC EPSILON RI SIGNALING PATHWAY
CORUM FYB-CARMA1-BCL-10-MALT1 COMPLEX
KERLEY RESPONSE TO CISPLATIN UP
ROETH TERT TARGETS DN
CORUM G PROTEIN COMPLEX BTK GNG1 GNG2
BOWIE RESPONSE TO TAMOXIFEN
NCI S1P S1P3 PATHWAY
HADDAD T LYMPHOCYTE AND NK PROGENITOR DN
ICHIBA GRAFT VERSUS HOST DISEASE 35D UP
ZHOU INFLAMMATORY RESPONSE LPS UP
FERRANDO LYL1 NEIGHBORS
CORUM SNX COMPLEX SNX1A SNX2 SNX4 LEPR
NETPATH TGFBETA RECEPTOR PATHWAY DOWN
WONG ENDMETRIUM CANCER UP
FURUKAWA DUSP6 TARGETS PCI35 UP
NING CHRONIC OBSTRUCTIVE PULMONARY DISEASE DN
FINAK BREAST CANCER SDPP SIGNATURE
NETPATH IL 3 PATHWAY DOWN
VANTVEER BREAST CANCER ESR1 DN
STEARMAN LUNG CANCER EARLY VS LATE DN
PARK APL PATHOGENESIS UP
REACTOME CD28 DEPENDENT VAV1 PATHWAY
REACTOME TOLL LIKE RECEPTOR 4 CASCADE
BROCKE APOPTOSIS REVERSED BY IL6
BIOCARTA D4GDI PATHWAY
LY AGING MIDDLE DN
CHANDRAN METASTASIS TOP50 DN
EGUCHI CELL CYCLE RB1 TARGETS
KEGG OTHER GLYCAN DEGRADATION
NCI P53DOWNSTREAMPATHWAY
REACTOME CD28 CO STIMULATION
CORUM CONDENSIN I COMPLEX
HUMMEL BURKITTS LYMPHOMA DN
GAL LEUKEMIC STEM CELL DN
LEE EARLY T LYMPHOCYTE DN
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION MONOCYTE DN
CORUM ITGA2B-ITGB3-TLN1 COMPLEX
HUANG DASATINIB RESISTANCE UP
HINATA NFKB TARGETS FIBROBLAST UP
WONG ENDMETRIUM CANCER DN
BIOCARTA SET PATHWAY
NCI ACTIVATION AND OLIGOMERIZATION OF BAK PROTEIN
REACTOME RHO GTPASE CYCLE
CHEOK RESPONSE TO MERCAPTOPURINE DN
KEGG PRIMARY IMMUNODEFICIENCY
CORUM CHROMOSOMAL PASSENGER COMPLEX CPC CDCA8 AURKB BIRC5
ZHANG INTERFERON RESPONSE
CHANG IMMORTALIZED BY HPV31 DN
MOHANKUMAR TLX1 TARGETS DN
MOOTHA HUMAN MITODB 6 2002
KEGG REGULATION OF ACTIN CYTOSKELETON
STEARMAN TUMOR FIELD EFFECT UP
CROONQUIST STROMAL STIMULATION UP
KEGG LEUKOCYTE TRANSENDOTHELIAL MIGRATION
BERENJENO TRANSFORMED BY RHOA REVERSIBLY DN
CHIARADONNA NEOPLASTIC TRANSFORMATION CDC25 UP
DORN ADENOVIRUS INFECTION 48HR UP
CORUM BRCA1 B COMPLEX
ZHANG RESPONSE TO CANTHARIDIN UP
KANG IMMORTALIZED BY TERT UP
KHETCHOUMIAN TRIM24 TARGETS UP
NAKAMURA METASTASIS MODEL UP
NCI CD28 DEPENDENT VAV1 PATHWAY
OUYANG PROSTATE CANCER PROGRESSION UP
HORIUCHI WTAP TARGETS UP
ONKEN UVEAL MELANOMA UP
NCI CMYB PATHWAY
WOO LIVER CANCER RECURRENCE UP
CASORELLI APL SECONDARY VS DE NOVO UP
CORUM ITGA4-ITGB1-VCAM1 COMPLEX
BIOCARTA SODD PATHWAY
DORN ADENOVIRUS INFECTION 32HR UP
MCCABE HOXC6 TARGETS DN
RIGGI EWING SARCOMA PROGENITOR UP
BIOCARTA TH1TH2 PATHWAY
NCI KITPATHWAY
KEGG JAK STAT SIGNALING PATHWAY
CLASPER LYMPHATIC VESSELS DURING METASTASIS DN
BUDHU LIVER CANCER METASTASIS DN
CROONQUIST NRAS SIGNALING DN
DER IFN BETA RESPONSE UP
BOQUEST STEM CELL DN
MORI PRE BI LYMPHOCYTE DN
TSAI DNAJB4 TARGETS UP
CORUM IL12B-IL12RB1-IL12RB2 COMPLEX
GARY CD5 TARGETS UP
NUNODA RESPONSE TO DASATINIB IMATINIB UP
GILDEA METASTASIS
REACTOME EICOSANOID LIGAND BINDING RECEPTORS
HAHTOLA SEZARY SYNDROM UP
RAY TARGETS OF P210 BCR ABL FUSION DN
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 10D DN
BASSO CD40 SIGNALING UP
MUELLER METHYLATED IN GLIOBLASTOMA
KEGG OLFACTORY TRANSDUCTION
CHANG POU5F1 TARGETS UP
TIAN TNF SIGNALING NOT VIA NFKB
KORKOLA EMBRYONAL CARCINOMA UP
IVANOVA HEMATOPOIESIS LATE PROGENITOR
BIOCARTA FCER1 PATHWAY
NAGASHIMA NRG1 SIGNALING UP
RAGHAVACHARI PLATELET SPECIFIC GENES
ZERBINI RESPONSE TO SULINDAC UP
WANG ESOPHAGUS CANCER VS NORMAL UP
NCI PTP1BPATHWAY
REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS
SU THYMUS
SASSON RESPONSE TO FORSKOLIN DN
SMID BREAST CANCER NORMAL LIKE UP
CHEMNITZ RESPONSE TO PROSTAGLANDIN E2 UP
AMUNDSON GAMMA RADIATION RESISTANCE
MATTIOLI MULTIPLE MYELOMA WITH 14Q32 TRANSLOCATIONS
REACTOME PLATELET AGGREGATION PLUG FORMATION
KEGG VIRAL MYOCARDITIS
BIOCARTA CTL PATHWAY
VERRECCHIA RESPONSE TO TGFB1 C1
ZHANG ANTIVIRAL RESPONSE TO RIBAVIRIN DN
KEGG LEISHMANIA INFECTION
NCI CD28 CO STIMULATION
NUTT GBM VS AO GLIOMA UP
KEGG FC GAMMA R MEDIATED PHAGOCYTOSIS
REACTOME COSTIMULATION BY THE CD28 FAMILY
KEGG TRYPTOPHAN METABOLISM
ELVIDGE HIF1A AND HIF2A TARGETS DN
YU MYC TARGETS DN
KYNG ENVIRONMENTAL STRESS RESPONSE NOT BY 4NQO IN OLD
KANNAN TP53 TARGETS UP
CHEN HOXA5 TARGETS 9HR UP
NCI NEF AND SIGNAL TRANSDUCTION
RORIE TARGETS OF EWSR1 FLI1 FUSION UP
CORUM ITGAV-ITGB3-NOV COMPLEX
SEKI INFLAMMATORY RESPONSE LPS UP
ST GA12 PATHWAY
KONDO HYPOXIA
GUTIERREZ WALDENSTROEMS MACROGLOBULINEMIA 2
GRAHAM CML QUIESCENT VS CML DIVIDING UP
CORUM PRB2/P130-MULTIMOLECULAR COMPLEX DNMT1 E2F5 SUV39H1 HDAC1 RBL2
CORUM ITGA4-PXN-GIT1 COMPLEX
CONCANNON APOPTOSIS BY EPOXOMICIN UP
PARK TRETINOIN RESPONSE AND PML RARA FUSION
LEE RECENT THYMIC EMIGRANT
ENGELMANN CANCER PROGENITORS UP
REACTOME P38MAPK EVENTS
LEE DIFFERENTIATING T LYMPHOCYTE
FONTAINE FOLLICULAR THYROID ADENOMA DN
FOSTER INFLAMMATORY RESPONSE LPS UP
BIOCARTA ASBCELL PATHWAY
SENESE HDAC1 TARGETS UP
LIU TARGETS OF VMYB VS CMYB DN
INGA TP53 TARGETS
KIM WT1 TARGETS UP
PEPPER CHRONIC LYMPHOCYTIC LEUKEMIA UP
MORI PLASMA CELL DN
KEGG CYTOSOLIC DNA SENSING PATHWAY
HOLLMAN APOPTOSIS VIA CD40 UP
HESS TARGETS OF HOXA9 AND MEIS1 DN
CROONQUIST NRAS SIGNALING UP
IIZUKA RECURRENT LIVER CANCER
CUI TCF21 TARGETS DN
BERTUCCI MEDULLARY VS DUCTAL BREAST CANCER UP
SMID BREAST CANCER RELAPSE IN BONE DN
CORUM MCL1-BAK1 COMPLEX
MATSUDA NATURAL KILLER DIFFERENTIATION
NCI XANTHINE FORMATION
RUTELLA RESPONSE TO HGF UP
HOSHIDA LIVER CANCER LATE RECURRENCE UP
PRAMOONJAGO SOX4 TARGETS UP
FERRANDO TAL1 NEIGHBORS
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 1
LU TUMOR ENDOTHELIAL MARKERS UP
VERHAAK AML WITH NPM1 MUTATED DN
KEGG FATTY ACID METABOLISM
REACTOME PD1 SIGNALING
ROSS LEUKEMIA WITH MLL FUSIONS
GRAHAM CML DIVIDING VS NORMAL QUIESCENT UP
BIOCARTA PML PATHWAY
CORUM RICH1/AMOT POLARITY COMPLEX FLAG-RICH1 PRECIPITATED
MARTORIATI MDM4 TARGETS NEUROEPITHELIUM UP
BIOCARTA NO2IL12 PATHWAY
BOYAULT LIVER CANCER SUBCLASS G5 DN
SWEET LUNG CANCER KRAS UP
BIOCARTA TCYTOTOXIC PATHWAY
TENEDINI MEGAKARYOCYTE MARKERS
HOFMANN MYELODYSPLASTIC SYNDROM RISK DN
CONRAD STEM CELL
SAKAI CHRONIC HEPATITIS VS LIVER CANCER DN
LINDSTEDT DENDRITIC CELL MATURATION A
RUGO UV RESPONSE
KYNG ENVIRONMENTAL STRESS RESPONSE NOT BY 4NQO IN WS
BASAKI YBX1 TARGETS DN
XU RESPONSE TO TRETINOIN UP
ELVIDGE HYPOXIA UP
REACTOME PLATELET ACTIVATION
RADMACHER AML PROGNOSIS
WATANABE ULCERATIVE COLITIS WITH CANCER DN
GRAHAM CML DIVIDING VS NORMAL DIVIDING UP
REACTOME INTEGRIN ALPHAIIBBETA3 SIGNALING
SA PROGRAMMED CELL DEATH
HOFFMANN IMMATURE TO MATURE B LYMPHOCYTE UP
CORUM CRM1-SURVIVIN-AURORAB MITOTIC COMPLEX
WU HBX TARGETS 3 UP
HO LIVER CANCER VASCULAR INVASION
FRIDMAN IMMORTALIZATION DN
ST TYPE I INTERFERON PATHWAY
KEGG NOD LIKE RECEPTOR SIGNALING PATHWAY
HOOI ST7 TARGETS DN
BIOCARTA NKCELLS PATHWAY
CORUM PLC-GAMMA-2-SLP-76-LYN-GRB2 COMPLEX
XU HGF TARGETS INDUCED BY AKT1 48HR UP
VART KSHV INFECTION ANGIOGENIC MARKERS UP
REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS
WILLIAMS ESR2 TARGETS DN
BIOCARTA IL22BP PATHWAY
PARK APL PATHOGENESIS DN
CORUM SRC-PRKCD-CDCP1 COMPLEX
SMIRNOV CIRCULATING ENDOTHELIOCYTES IN CANCER DN
WIKMAN ASBESTOS LUNG CANCER DN
KORKOLA TERATOMA UP
DELYS THYROID CANCER UP
TSAI RESPONSE TO IONIZING RADIATION
KRISHNAN FURIN TARGETS UP
DIRMEIER LMP1 RESPONSE EARLY
KEGG INTESTINAL IMMUNE NETWORK FOR IGA PRODUCTION
AMIT SERUM RESPONSE 240 MCF10A
NCI INTEGRIN CELL SURFACE INTERACTIONS
MARSON FOXP3 TARGETS UP
BENNETT SYSTEMIC LUPUS ERYTHEMATOSUS
ZHAN V1 LATE DIFFERENTIATION GENES UP
GAUSSMANN MLL AF4 FUSION TARGETS E UP
NCI NFAT TFPATHWAY
ONDER CDH1 TARGETS 3 DN
TARTE PLASMA CELL VS B LYMPHOCYTE DN
CORUM BRCA1 C COMPLEX
SPIELMAN LYMPHOBLAST EUROPEAN VS ASIAN 2FC DN
HELLEBREKERS SILENCED DURING TUMOR ANGIOGENESIS
NAKAYAMA SOFT TISSUE TUMORS PCA1 UP
LIAN LIPA TARGETS 6M
WINTER HYPOXIA METAGENE
BROWNE HCMV INFECTION 8HR UP
MARKS HDAC TARGETS UP
MCBRYAN PUBERTAL BREAST 6 7WK DN
REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN
TAVOR CEBPA TARGETS UP
PICCALUGA ANGIOIMMUNOBLASTIC LYMPHOMA UP
NETPATH TNF ALPHA PATHWAY UP
NOJIMA SFRP2 TARGETS DN
KEGG T CELL RECEPTOR SIGNALING PATHWAY
BROWNE HCMV INFECTION 2HR UP
TAVOR CEBPA TARGETS DN
SESTO RESPONSE TO UV C3
YANAGISAWA LUNG CANCER RECURRENCE
REACTOME DEATH RECEPTOR SIGNALLING
GRAHAM CML DIVIDING VS NORMAL QUIESCENT DN
NCI ANTHRAXPATHWAY
ZHAN MULTIPLE MYELOMA DN
NCI CASPASE PATHWAY
NETPATH IL 2 PATHWAY
BIOCARTA TCAPOPTOSIS PATHWAY
CORUM PARVB-ARHGEF6 COMPLEX
BIOCARTA P38MAPK PATHWAY
REACTOME AXON GUIDANCE
ROSTY CERVICAL CANCER PROLIFERATION CLUSTER
GRANDVAUX IRF3 TARGETS UP
HADDAD B LYMPHOCYTE PROGENITOR
ROZANOV MMP14 TARGETS UP
ZHU CMV ALL UP
KEGG SYSTEMIC LUPUS ERYTHEMATOSUS
NCI SEMA4D IN SEMAPHORIN SIGNALING
REACTOME SEMA4D IN SEMAPHORIN SIGNALING
SCHLOSSER SERUM RESPONSE UP
CORUM BRCA1-BARD1-UBCH7C COMPLEX
CORUM TGF-BETA RECEPTOR II-TGF-BETA RECEPTOR I-TGF-BETA3 COMPLEX
BIOCARTA SPPA PATHWAY
LEE LIVER CANCER HEPATOBLAST
NAGASHIMA EGF SIGNALING UP
SMID BREAST CANCER RELAPSE IN PLEURA DN
KEGG TYPE I DIABETES MELLITUS
AMIT DELAYED EARLY GENES
REACTOME TCR SIGNALING
RUGO STRESS RESPONSE SUBSET H
REACTOME CLASSICAL ANTIBODY MEDIATED COMPLEMENT ACTIVATION
KYNG DNA DAMAGE BY GAMMA AND UV RADIATION
IIZUKA LIVER CANCER PROGRESSION G2 G3 DN
CORUM PLC-GAMMA-2-SYK-LAT-FCR-GAMMA COMPLEX
NOJIMA SFRP2 TARGETS UP
RHEIN ALL GLUCOCORTICOID THERAPY UP
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL UP
WANG BARRETTS ESOPHAGUS AND ESOPHAGUS CANCER DN
WHITEFORD PEDIATRIC CANCER MARKERS
MARTINELLI IMMATURE NEUTROPHIL DN
BOYAULT LIVER CANCER SUBCLASS G3 DN
AUJLA IL22 AND IL17A SIGNALING
NCI EPHRINBREVPATHWAY
CORUM BRCA1-CTIP-ZBRK1 REPRESSOR COMPLEX
ZHAN MULTIPLE MYELOMA HP DN
LEE LIVER CANCER MYC TGFA UP
SCHUHMACHER MYC TARGETS DN
CORUM ITGAV-ITGB3-COL4A3 COMPLEX
LEE LIVER CANCER DENA UP
HALMOS CEBPA TARGETS UP
NCI A4B1 PAXINDEP PATHWAY
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 9
ENK UV RESPONSE EPIDERMIS UP
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 10D UP
CORUM WIP-WASP-ACTIN-MYOSIN-IIA COMPLEX
SAGIV CD24 TARGETS DN
REACTOME MYD88 CASCADE
WIELAND UP BY HBV INFECTION
COATES MACROPHAGE M1 VS M2 DN
HOFFMANN SMALL PRE BII TO IMMATURE B LYMPHOCYTE UP
ST INTERFERON GAMMA PATHWAY
MAHADEVAN RESPONSE TO MP470 DN
ZHAN MULTIPLE MYELOMA CD1 UP
LEE INTRATHYMIC T PROGENITOR
SMID BREAST CANCER LUMINAL A DN
TSAI RESPONSE TO RADIATION THERAPY
NCI CXCR3PATHWAY
LU TUMOR ANGIOGENESIS UP
HUPER BREAST BASAL VS LUMINAL DN
HARRIS HYPOXIA
NETPATH KIT RECEPTOR PATHWAY UP
REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS
KEGG NATURAL KILLER CELL MEDIATED CYTOTOXICITY
KEGG BUTANOATE METABOLISM
KARAKAS TGFB1 SIGNALING
NCI BH3 ONLY PROTEINS ASSOCIATE WITH AND INACTIVATE ANTI APOPTOTIC BCL 2 MEMBERS
RUIZ TNC TARGETS DN
WU SILENCED BY METHYLATION IN BLADDER CANCER
KAN RESPONSE TO ARSENIC TRIOXIDE
DIAZ CHRONIC MEYLOGENOUS LEUKEMIA DN
KEGG VALINE LEUCINE AND ISOLEUCINE DEGRADATION
SOUCEK MYC TARGETS
ENGELMANN CANCER PROGENITORS DN
BILBAN B CLL LPL DN
SCIAN INVERSED TARGETS OF TP53 AND TP73 DN
KEGG B CELL RECEPTOR SIGNALING PATHWAY
IZADPANAH STEM CELL ADIPOSE VS BONE UP
TOMLINS METASTASIS DN
OZANNE AP1 TARGETS UP
ZHAN MULTIPLE MYELOMA LB DN
LEE LIVER CANCER SURVIVAL UP
KEGG AUTOIMMUNE THYROID DISEASE
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION HSC UP
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION SUSTAINED IN GRANULOCYTE DN
FLECHNER BIOPSY KIDNEY TRANSPLANT REJECTED VS OK UP
CORUM CD20-LCK-FYN-P75/80 COMPLEX
ZHAN MULTIPLE MYELOMA SPIKED
CHIN BREAST CANCER COPY NUMBER UP
LEE LIVER CANCER ACOX1 UP
RUTELLA RESPONSE TO HGF DN
CORUM ITGA4-ITGB1-THBS2 COMPLEX
WANG ESOPHAGUS CANCER PROGRESSION UP
BIOCARTA GSK3 PATHWAY
EINAV INTERFERON SIGNATURE IN CANCER
LEI MYB TARGETS
LEE LIVER CANCER SURVIVAL DN
GUENTHER GROWTH SPHERICAL VS ADHERENT DN
AMIT SERUM RESPONSE 40 MCF10A
PUJANA ATM PCC NETWORK
HELLER HDAC TARGETS SILENCED BY METHYLATION UP
BIDUS METASTASIS DN
LINDGREN BLADDER CANCER HIGH RECURRENCE
CHIARETTI T ALL RELAPSE PROGNOSIS
MAHADEVAN IMATINIB RESISTANCE DN
WONG ENDOMETRIAL CANCER LATE
BIOCARTA HSP27 PATHWAY
MARTINELLI IMMATURE NEUTROPHIL UP
ZHU CMV 8 HR UP
GAUSSMANN MLL AF4 FUSION TARGETS F UP
BIERIE INFLAMMATORY RESPONSE TGFB1
MARSON FOXP3 TARGETS DN
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 8D UP
SCHUETZ BREAST CANCER DUCTAL INVASIVE UP
DUNNE TARGETS OF AML1 MTG8 FUSION UP
REACTOME PECAM1 INTERACTIONS
XU HGF TARGETS INDUCED BY AKT1 6HR
EBAUER TARGETS OF PAX3 FOXO1 FUSION UP
ONDER CDH1 TARGETS 2 DN
ZHAN MULTIPLE MYELOMA CD1 VS CD2 UP
ALCALAY AML BY NPM1 LOCALIZATION DN
SENESE HDAC3 TARGETS UP
LIAN LIPA TARGETS 3M
KEGG CHEMOKINE SIGNALING PATHWAY
FUJII YBX1 TARGETS UP
FERREIRA EWINGS SARCOMA UNSTABLE VS STABLE UP
CHARAFE BREAST CANCER LUMINAL VS MESENCHYMAL DN
XU HGF SIGNALING NOT VIA AKT1 6HR
NCI RAC1 PATHWAY
JISON SICKLE CELL DISEASE UP
MCBRYAN PUBERTAL BREAST 3 4WK DN
BIOCARTA CTLA4 PATHWAY
XU HGF SIGNALING NOT VIA AKT1 48HR UP
TARTE PLASMA CELL VS PLASMABLAST UP
DASU IL6 SIGNALING UP
LEE LIVER CANCER DENA DN
HUPER BREAST BASAL VS LUMINAL UP
CROONQUIST NRAS VS STROMAL STIMULATION UP
REACTOME METABOLISM OF LIPIDS AND LIPOPROTEINS
ZUCCHI METASTASIS DN
HOFFMANN PRE BI TO LARGE PRE BII LYMPHOCYTE DN
DEURIG T CELL PROLYMPHOCYTIC LEUKEMIA DN
SMID BREAST CANCER BASAL UP
FERRANDO T ALL WITH MLL ENL FUSION UP
ACEVEDO LIVER CANCER WITH H3K27ME3 UP
NCI TCRJNKPATHWAY
LINDGREN BLADDER CANCER CLUSTER 1 DN
WINTER HYPOXIA DN
Color legend
q-value10.20.050.010.0010.0001
Color
TABLE OF Q-VALUES
ehrlichia chaffeensis arkansaehrlichia chaffeensis wakullaGeneSet Name
0.00000 0.00000HSIAO_LIVER_SPECIFIC_GENES
0.00000 0.00000MOOTHA_VOXPHOS
0.00029 0.00006NETPATH_IL_2_PATHWAY_UP
0.00011 0.00000NETPATH_IL_4_PATHWAY_UP
0.00744 0.00022NETPATH_IL_1_PATHWAY_UP
0.00855 0.00000NETPATH_B_CELL_RECEPTOR_PATHWAY
0.01457 0.00122NETPATH_B_CELL_RECEPTOR_PATHWAY_UP
0.00021 0.00002NCI_AMB2_NEUTROPHILS_PATHWAY
0.00093 0.00052NCI_TXA2PATHWAY
0.00000 0.00047NCI_EXOCYTOSIS_OF_ALPHA_GRANULE_
0.00007 0.00000NETPATH_IL_5_PATHWAY_UP
0.00785 0.00075NETPATH_IL_5_PATHWAY
0.01625 0.00191NCI_IL2_1PATHWAY
0.00000 0.00000NETPATH_IL_3_PATHWAY_UP
0.00063 0.00011NETPATH_IL_2_PATHWAY_DOWN
0.00000 0.00000NCI_IL12_2PATHWAY
0.00001 0.00000NETPATH_IL_4_PATHWAY_DOWN
0.00160 0.00010NCI_CXCR4_PATHWAY
0.00000 0.00005NETPATH_B_CELL_RECEPTOR_PATHWAY_DOWN
0.00000 0.00000NETPATH_T_CELL_RECEPTOR_PATHWAY
0.00003 0.00000NETPATH_IL_6_PATHWAY_UP
0.01712 0.00592NETPATH_KIT_RECEPTOR_PATHWAY
0.01308 0.00116GERY_CEBP_TARGETS
0.00034 0.00004NETPATH_IL_7_PATHWAY_UP
0.00000 0.00004NCI_IL27PATHWAY
0.00465 0.00029NETPATH_IL_4_PATHWAY
0.00000 0.00020NCI_IL23PATHWAY
0.00037 0.00000SA_MMP_CYTOKINE_CONNECTION
0.00213 0.00000NCI_TCR_PATHWAY
0.00211 0.00007NETPATH_T_CELL_RECEPTOR_PATHWAY_DOWN
0.01628 0.00041NCI_CD8TCRPATHWAY
0.00096 0.00007NCI_PI3KCIPATHWAY
0.00000 0.00000NCI_IL6_7PATHWAY
0.00697 0.00024NCI_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL
0.01156 0.00320NCI_IL4_2PATHWAY
0.00000 0.00001NCI_IL12_STAT4PATHWAY
0.00584 0.00254ST_TUMOR_NECROSIS_FACTOR_PATHWAY
0.00005 0.00007NCI_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL
0.00333 0.00083ST_STAT3_PATHWAY
0.00097 0.00000NETPATH_IL_9_PATHWAY_UP
0.01199 0.00583NCI_INTEGRIN_ALPHAIIBBETA3_SIGNALING
0.00672 0.00526CORUM_ITGA2B-ITGB3-CD9-GP1B-CD47_COMPLEX
0.00277 0.00064ST_T_CELL_SIGNAL_TRANSDUCTION
0.00014 0.00000RICKMAN_METASTASIS_DN
0.15706 0.09159NCI_COLLAGEN_ADHESION_VIA_ALPHA_2_BETA_1_GLYCOPROTEIN
0.00000 0.00008TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN
0.00082 0.00114BIOCARTA_IL10_PATHWAY
0.19121 0.14891ITO_PTTG1_TARGETS_UP
0.00000 0.00000RASHI_RESPONSE_TO_IONIZING_RADIATION_6
0.17971 0.00730BIOCARTA_RHO_PATHWAY
0.01198 0.00447MAHAJAN_RESPONSE_TO_IL1A_UP
0.01089 0.04046WEINMANN_ADAPTATION_TO_HYPOXIA_DN
0.06162 0.06758CORUM_ITGA2B-ITGB3-CD9_COMPLEX
0.06906 0.04999CORUM_BRCA1-LMO4-CTIP_COMPLEX
0.04449 0.01440FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP
0.00007 0.00000LINDSTEDT_DENDRITIC_CELL_MATURATION_B
0.17481 0.01394BIOCARTA_IL1R_PATHWAY
0.11469 0.06228REACTOME_THE_ROLE_OF_NEF_IN_HIV1_REPLICATION_AND_DISEASE_PATHOGENESIS
0.09364 0.00096HUANG_FOXA2_TARGETS_DN
0.00000 0.00000RADAEVA_RESPONSE_TO_IFNA1_UP
0.01726 0.00337LUI_THYROID_CANCER_CLUSTER_4
0.13942 0.04218NCI_A4B1_A4B7_PATHWAY
0.00000 0.00005COATES_MACROPHAGE_M1_VS_M2_UP
0.00254 0.00166BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX
0.00076 0.00056MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP
0.00016 0.00111BIOCARTA_THELPER_PATHWAY
0.14618 0.12465CORUM_MCL1-NOXA_COMPLEX
0.02605 0.13525MUNSHI_MULTIPLE_MYELOMA_UP
0.05920 0.00533WANG_SMARCE1_TARGETS_UP
0.12490 0.00119AMIT_EGF_RESPONSE_480_HELA
0.00046 0.00032JEON_SMAD6_TARGETS_UP
0.12501 0.10426SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN
0.15185 0.06953LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT
0.03100 0.07745NCI_GENERATION_OF_SECOND_MESSENGER_MOLECULES
0.18351 0.14172HASINA_NOL7_TARGETS_UP
0.00027 0.00039KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN
0.01728 0.00605ALCALA_APOPTOSIS
0.10685 0.00428BIOCARTA_MCM_PATHWAY
0.00286 0.00856REACTOME_E2F_TRANSCRIPTIONAL_TARGETS_AT_G1_S
0.00000 0.00000LENAOUR_DENDRITIC_CELL_MATURATION_DN
0.00017 0.00184BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN
0.00359 0.01320KUMAR_TARGETS_OF_MLL_AF9_FUSION
0.15184 0.09038CORUM_ITGA9-ITGB1-VCAM1_COMPLEX
0.03945 0.11672KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP
0.00044 0.00344TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP
0.00467 0.00000KANG_DOXORUBICIN_RESISTANCE_UP
0.16716 0.07362LI_CYTIDINE_ANALOG_PATHWAY
0.11433 0.00777COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP
0.01020 0.00109PAL_PRMT5_TARGETS_DN
0.05962 0.00443SENGUPTA_EBNA1_ANTICORRELATED
0.01069 0.00183CERVERA_SDHB_TARGETS_1_UP
0.05834 0.12168NAKAMURA_METASTASIS
0.14485 0.10957CORUM_PRB2/P130-MULTIMOLECULAR_COMPLEX_RB2_E2F5_HDAC1_SUV39H1_P300
0.00479 0.00352NIELSEN_SYNOVIAL_SARCOMA_DN
0.00000 0.00000REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES
0.00001 0.00000SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP
0.16419 0.08869CORUM_CHROMOSOMAL_PASSENGER_COMPLEX_CPC_INCENP_BIRC5_AURKB
0.00015 0.00000SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP
0.07404 0.00037AMIT_EGF_RESPONSE_120_HELA
0.00549 0.00161FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP
0.05149 0.18155REACTOME_APOPTOSIS
0.13478 0.03243KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION
0.00000 0.00000MCLACHLAN_DENTAL_CARIES_UP
0.01777 0.00334REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE
0.02606 0.00261GAJATE_RESPONSE_TO_TRABECTEDIN_UP
0.11657 0.13220KYNG_DNA_DAMAGE_BY_UV
0.01817 0.00717BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN
0.11070 0.03285CORUM_CHROMOSOMAL_PASSENGER_COMPLEX_CPC_INCENP_CDCA8_BIRC5_AURKB
0.18336 0.04541BIOCARTA_TCR_PATHWAY
0.12179 0.09427CORUM_PLC-GAMMA-2-LAT_COMPLEX
0.00000 0.00000HELLER_SILENCED_BY_METHYLATION_UP
0.03115 0.01808KEGG_CELL_ADHESION_MOLECULES_CAMS
0.09109 0.14168CORUM_CBL-SLP-76-GRB2_COMPLEX_FC_RECEPTOR_GAMMA-R1_STIMULATED
0.11644 0.10943GOZGIT_ESR1_TARGETS_DN
0.06604 0.00442LAU_APOPTOSIS_CDKN2A_UP
0.09598 0.02136NCI_P38ALPHABETAPATHWAY
0.00013 0.00002BIOCARTA_MONOCYTE_PATHWAY
0.00000 0.00000MOOTHA_FFA_OXYDATION
0.00000 0.00000SMID_BREAST_CANCER_LUMINAL_B_DN
0.02726 0.00015LEE_LIVER_CANCER_CIPROFIBRATE_UP
0.09965 0.00506BERENJENO_TRANSFORMED_BY_RHOA_UP
0.16432 0.03410CORUM_ITGA4-ITGB1-CD53_COMPLEX
0.14449 0.05936CORUM_ITGAV-ITGB8-MMP14-TGFB1_COMPLEX
0.10047 0.16009CORUM_REL-MAP3K8-RELA-TNIP2-PAPOLA_COMPLEX
0.00000 0.00005REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL
0.02791 0.00435MARSON_FOXP3_TARGETS_STIMULATED_UP
0.02049 0.13139BIOCARTA_IL17_PATHWAY
0.06498 0.03121CORUM_ARP2/3_PROTEIN_COMPLEX
0.00000 0.00000VERHAAK_AML_WITH_NPM1_MUTATED_UP
0.06408 0.01188AMIT_EGF_RESPONSE_40_MCF10A
0.00013 0.00009REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES
0.00009 0.00052REACTOME_G_ALPHA_I_SIGNALLING_EVENTS
0.00000 0.00000TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN
0.13178 0.02969NCI_ACTIVATION__MYRISTOLYATION_OF_BID_AND_TRANSLOCATION_TO_MITOCHONDRIA
0.11439 0.12283SPIRA_SMOKERS_LUNG_CANCER_UP
0.19549 0.13563CORUM_IKBEPSILON-RELA-CREL_COMPLEX
0.05883 0.05715ROSS_ACUTE_MYELOID_LEUKEMIA_CBF
0.15171 0.04468CHASSOT_SKIN_WOUND
0.00003 0.00000TIAN_TNF_SIGNALING_VIA_NFKB
0.00000 0.00000KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.03261 0.01955GOLUB_ALL_VS_AML_DN
0.04003 0.00860KEGG_APOPTOSIS
0.16701 0.02218CORUM_NFKB1-NFKB2-REL-RELA-RELB_COMPLEX
0.18284 0.09481CORUM_13S_CONDENSIN_COMPLEX
0.00696 0.03487ZHAN_MULTIPLE_MYELOMA_MF_UP
0.00033 0.00050CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN
0.00697 0.00068HOSHIDA_LIVER_CANCER_SURVIVAL_UP
0.00013 0.00000CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN
0.00123 0.00006MISSIAGLIA_REGULATED_BY_METHYLATION_UP
0.02298 0.08619NCI_CLASSICAL_ANTIBODY_MEDIATED_COMPLEMENT_ACTIVATION
0.03449 0.00422CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN
0.02314 0.00196NCI_ATF2_PATHWAY
0.09165 0.03547ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN
0.01658 0.00835GEORGANTAS_HSC_MARKERS
0.03342 0.02416RHODES_UNDIFFERENTIATED_CANCER
0.17109 0.17336CORUM_BLOC-2_BIOGENESIS_OF_LYSOSOME-RELATED_ORGANELLES_COMPLEX_2
0.02088 0.02693KONDO_PROSTATE_CANCER_WITH_H3K27ME3
0.02243 0.00487REACTOME_SEMAPHORIN_INTERACTIONS
0.06161 0.00288KEGG_ASTHMA
0.00125 0.00016BOYLAN_MULTIPLE_MYELOMA_D_DN
0.00000 0.00017KIM_LRRC3B_TARGETS
0.02845 0.00165KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP
0.11533 0.06560DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP
0.12307 0.02046BIOCARTA_UCALPAIN_PATHWAY
0.00000 0.00000WOO_LIVER_CANCER_RECURRENCE_DN
0.00309 0.00627REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS
0.00000 0.00000RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN
0.04175 0.00003VERNELL_RETINOBLASTOMA_PATHWAY_UP
0.00468 0.00037MULLIGHAN_MLL_SIGNATURE_2_UP
0.00000 0.00022CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN
0.16369 0.08703CORUM_ERG-JUN-FOS_DNA-PROTEIN_COMPLEX
0.18332 0.02072GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP
0.16319 0.14927SCHAVOLT_TARGETS_OF_TP53_AND_TP63
0.00144 0.00056DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
0.17299 0.04314NETPATH_IL_6_PATHWAY
0.04697 0.04300BIOCARTA_CYTOKINE_PATHWAY
0.01151 0.00714SEIKE_LUNG_CANCER_POOR_SURVIVAL
0.00013 0.00184AMIT_EGF_RESPONSE_20_HELA
0.05198 0.01408GALI_TP53_TARGETS_APOPTOTIC_UP
0.02816 0.04195NCI_GLYPICAN_1PATHWAY
0.06378 0.00236NETPATH_IL_3_PATHWAY
0.19446 0.10944CORUM_BRCA1-IRIS-PRE-REPLICATION_COMPLEX
0.08875 0.15913NCI_COLLAGEN_ADHESION_VIA_GP_IV
0.07723 0.07155BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP
0.13113 0.08007CORUM_CIN85-CBL-SH3GL2_COMPLEX
0.00161 0.00004MARZEC_IL2_SIGNALING_UP
0.00871 0.00448BIOCARTA_BLYMPHOCYTE_PATHWAY
0.00653 0.00183FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_DN
0.00871 0.00486LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN
0.00000 0.00000BOYLAN_MULTIPLE_MYELOMA_C_D_DN
0.02725 0.00133VERRECCHIA_RESPONSE_TO_TGFB1_C2
0.12793 0.08461CROMER_TUMORIGENESIS_UP
0.00696 0.00628FRIDMAN_SENESCENCE_UP
0.02731 0.00094WU_HBX_TARGETS_2_DN
0.13773 0.08944CORUM_SNX_COMPLEX_SNX11A24_PDGF_RECEPTOR
0.00029 0.00001MAHADEVAN_RESPONSE_TO_MP470_UP
0.00947 0.00156FERRARI_RESPONSE_TO_FENRETINIDE_UP
0.19761 0.05159KEGG_PANCREATIC_CANCER
0.01229 0.15357DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_UP
0.01590 0.00829BIOCARTA_TID_PATHWAY
0.02318 0.00056AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_2G
0.00790 0.00035AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_8G
0.00000 0.00000SANA_RESPONSE_TO_IFNG_UP
0.03740 0.04151CASTELLANO_NRAS_TARGETS_DN
0.01664 0.00733CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN
0.01220 0.01512OHASHI_AURKB_TARGETS
0.05179 0.05492NCI_ENDOTHELINPATHWAY
0.18210 0.06987ELVIDGE_HIF2A_TARGETS_UP
0.00000 0.00000BOYLAN_MULTIPLE_MYELOMA_PCA1_UP
0.02293 0.11208WU_HBX_TARGETS_1_UP
0.07286 0.13271WANG_BARRETTS_ESOPHAGUS_DN
0.01642 0.10796NCI_ALPHASYNUCLEIN_PATHWAY
0.00468 0.00850GNATENKO_PLATELET_SIGNATURE
0.15314 0.04153DASU_IL6_SIGNALING_SCAR_DN
0.02324 0.00635HOEBEKE_LYMPHOID_STEM_CELL_UP
0.15377 0.08125CORUM_ITGAV-ITGB3-ADAM15_COMPLEX
0.00000 0.00000KEGG_PROPANOATE_METABOLISM
0.07944 0.09565LU_TUMOR_ENDOTHELIAL_MARKERS_DN
0.00000 0.00000MOOTHA_MITOCHONDRIA
0.01306 0.00849NCI_E2F_TRANSCRIPTIONAL_TARGETS_AT_G1_S
0.07413 0.01406REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS
0.12931 0.02839SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES
0.00000 0.00000MOSERLE_IFNA_RESPONSE
0.00044 0.00001MULLIGHAN_MLL_SIGNATURE_1_UP
0.04470 0.08701HOLLMAN_APOPTOSIS_VIA_CD40_DN
0.00000 0.00000RODWELL_AGING_KIDNEY_UP
0.00786 0.00067REACTOME_TOLL_RECEPTOR_CASCADES
0.11753 0.08705BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP
0.00039 0.00022ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP
0.02324 0.01538GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_DN
0.13853 0.15849KENNY_CTNNB1_TARGETS_UP
0.14544 0.03885NCI_A4B1_PAXDEP_PATHWAY
0.00700 0.00000CROONQUIST_IL6_DEPRIVATION_DN
0.01782 0.06001BIOCARTA_IL7_PATHWAY
0.00040 0.00000CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP
0.00024 0.00012BIOCARTA_GRANULOCYTES_PATHWAY
0.11079 0.11084LINDSTEDT_DENDRITIC_CELL_MATURATION_C
0.04000 0.01140OSMAN_BLADDER_CANCER_UP
0.00019 0.00034VALK_AML_CLUSTER_5
0.00000 0.00000MORI_IMMATURE_B_LYMPHOCYTE_UP
0.00561 0.00973REACTOME_ACTIVATED_TLR4_SIGNALLING
0.05459 0.01794HUTTMANN_B_CLL_POOR_SURVIVAL_UP
0.04510 0.00131ELVIDGE_HYPOXIA_BY_DMOG_UP
0.04113 0.00947BIOCARTA_TOLL_PATHWAY
0.06650 0.01506BROWNE_HCMV_INFECTION_48HR_UP
0.02050 0.01445BIOCARTA_IL2RB_PATHWAY
0.00890 0.02221NCI_PHOSPHORYLATION_OF_CD3_AND_TCR_ZETA_CHAINS
0.07305 0.01636REACTOME_CELLEXTRACELLULAR_MATRIX_INTERACTIONS
0.00511 0.00265OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
0.02910 0.00000PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP
0.14816 0.09912CORUM_PLC-GAMMA-2-SLP-76_COMPLEX
0.01839 0.00110VERRECCHIA_EARLY_RESPONSE_TO_TGFB1
0.03577 0.05667NCI_ACTIVATION_OF_PRO_CASPASE_8
0.01760 0.00025CHEOK_RESPONSE_TO_HD_MTX_UP
0.05509 0.07788CORUM_ETS2-FOS-JUN_COMPLEX
0.05114 0.00107PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN
0.08874 0.02625ELVIDGE_HIF1A_TARGETS_DN
0.17544 0.08863MORI_SMALL_PRE_BII_LYMPHOCYTE_UP
0.02322 0.00197GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN
0.17313 0.05165CORUM_IL6ST-PRKCD-STAT3_COMPLEX
0.00306 0.00822KUNINGER_IGF1_VS_PDGFB_TARGETS_DN
0.17968 0.06248LI_CISPLATIN_RESISTANCE_DN
0.18336 0.19698BORCZUK_MALIGNANT_MESOTHELIOMA_DN
0.09228 0.00614MONTERO_THYROID_CANCER_POOR_SURVIVAL_UP
0.02812 0.01391BIOCARTA_TOB1_PATHWAY
0.00000 0.00000HAHTOLA_SEZARY_SYNDROM_DN
0.00000 0.00000TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP
0.00034 0.00004REACTOME_CLASS_A1_RHODOPSIN_LIKE_RECEPTORS
0.02946 0.00022THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN
0.00000 0.00000ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP
0.05706 0.01498KOYAMA_SEMA3B_TARGETS_UP
0.05826 0.06209ZHU_CMV_24_HR_UP
0.00068 0.00000GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN
0.04646 0.03586MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN
0.04447 0.09594REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA
0.14628 0.01382CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP
0.04351 0.01520HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN
0.03402 0.01101THUM_MIR21_TARGETS_HEART_DISEASE_UP
0.01143 0.00085MCBRYAN_PUBERTAL_BREAST_4_5WK_UP
0.09111 0.08131CORUM_ITGA2B-ITGB3-F11R_COMPLEX
0.00000 0.00000MORI_LARGE_PRE_BII_LYMPHOCYTE_DN
0.03759 0.01139YAGI_AML_FAB_MARKERS
0.18277 0.01445NETPATH_TGFBETA_RECEPTOR_PATHWAY_UP
0.00000 0.00000CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN
0.18667 0.07693KYNG_DNA_DAMAGE_BY_4NQO
0.00005 0.00002BIOCARTA_NKT_PATHWAY
0.09353 0.00274NCI_IL2_STAT5PATHWAY
0.00697 0.02739YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5
0.14367 0.17384CORUM_ITGA2B-ITGB3_COMPLEX
0.00155 0.01382MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN
0.11444 0.02257RODRIGUES_DCC_TARGETS_UP
0.00000 0.00000BROWNE_INTERFERON_RESPONSIVE_GENES
0.00003 0.00000TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN
0.00000 0.00000WILENSKY_RESPONSE_TO_DARAPLADIB
0.00026 0.00001PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN
0.00000 0.00000REACTOME_SIGNALING_IN_IMMUNE_SYSTEM
0.01826 0.00022ROETH_TERT_TARGETS_UP
0.00046 0.00063BIOCARTA_LAIR_PATHWAY
0.04656 0.08132TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP
0.00024 0.00000LE_EGR2_TARGETS_UP
0.07335 0.12530AKL_HTLV1_INFECTION_DN
0.11833 0.09884RICKMAN_HEAD_AND_NECK_CANCER_D
0.03910 0.03040DAZARD_UV_RESPONSE_CLUSTER_G3
0.01555 0.15802IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN
0.00024 0.00421CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP
0.00001 0.00002OSADA_ASCL1_TARGETS_DN
0.00036 0.00068BIOCARTA_LYM_PATHWAY
0.00475 0.00144NUYTTEN_EZH2_TARGETS_UP
0.00000 0.00000DUTTA_APOPTOSIS_VIA_NFKB
0.02663 0.00241CHUNG_BLISTER_CYTOTOXICITY_DN
0.16506 0.10059CORUM_ITGAV-ITGB3-CD47-FCER2_COMPLEX
0.00007 0.00650DER_IFN_GAMMA_RESPONSE_UP
0.00024 0.00017MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP
0.01761 0.01391REACTOME_PROSTANOID_HORMONES
0.09225 0.15386KANG_CISPLATIN_RESISTANCE_UP
0.00123 0.00006RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP
0.01092 0.00039ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
0.07913 0.03887BIOCARTA_ERYTH_PATHWAY
0.01021 0.00276NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP
0.00218 0.02717HENDRICKS_SMARCA4_TARGETS_DN
0.00936 0.00209NEWMAN_ERCC6_TARGETS_UP
0.13511 0.03294CORUM_TNF-ALPHA/NF-KAPPA_B_SIGNALING_COMPLEX_CHUK_KPNA3_NFKB2_NFKBIB_REL_IKBKG__NFKB1_NFKBIE_RELB__NFKBIA_RELA_TNIP2
0.01496 0.03562HEIDENBLAD_AMPLICON_12P11_12_DN
0.01329 0.01853REACTOME_TOLL_LIKE_RECEPTOR_9_CASCADE
0.17706 0.08528XU_CREBBP_TARGETS_DN
0.00000 0.00000RAMALHO_STEMNESS_DN
0.00000 0.00000FOSTER_INFLAMMATORY_RESPONSE_LPS_DN
0.11711 0.02417REACTOME_BASIGIN_INTERACTIONS
0.00003 0.00027FINETTI_BREAST_CANCER_KINOME_GREEN
0.00000 0.00000GAURNIER_PSMD4_TARGETS
0.12797 0.14057CORUM_TGF-BETA_RECEPTOR_II-TGF-BETA_RECEPTOR_I-TGF-BETA1_COMPLEX
0.00000 0.00000FARMER_BREAST_CANCER_CLUSTER_1
0.00010 0.00070GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3
0.03264 0.00974BIOCARTA_HIVNEF_PATHWAY
0.02810 0.04099SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER
0.00927 0.00681CLAUS_PGR_POSITIVE_MENINGIOMA_DN
0.00000 0.00000MARKEY_RB1_CHRONIC_LOF_DN
0.19149 0.17863CORUM_CIN85-SH3GL2_COMPLEX
0.02138 0.00730NCI_CD8TCRDOWNSTREAMPATHWAY
0.00000 0.00001REACTOME_FORMATION_OF_PLATELET_PLUG
0.00047 0.00032GESERICK_TERT_TARGETS_DN
0.00000 0.00006REACTOME_PLATELET_DEGRANULATION
0.11944 0.02486STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN
0.04018 0.00009AMIT_SERUM_RESPONSE_120_MCF10A
0.17274 0.01971BIOCARTA_SRCRPTP_PATHWAY
0.03368 0.00619APPEL_IMATINIB_RESPONSE
0.03374 0.05125BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN
0.00001 0.00101MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN
0.00000 0.00000LEE_LIVER_CANCER_MYC_E2F1_UP
0.01666 0.04322BASSO_HAIRY_CELL_LEUKEMIA_DN
0.07589 0.03686TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_DN
0.00175 0.00022GEISS_RESPONSE_TO_DSRNA_UP
0.00221 0.00050SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1
0.17318 0.07563CORUM_LCK-SLP76-PLC-GAMMA-1-LAT_COMPLEX_PERVANADATE-ACTIVATED
0.07185 0.04558BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN
0.09979 0.02576ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP
0.00090 0.00063HAHTOLA_CTCL_PATHOGENESIS
0.01722 0.01107REACTOME_GPCR_LIGAND_BINDING
0.00043 0.00009GRUETZMANN_PANCREATIC_CANCER_UP
0.16268 0.15053OKUMURA_INFLAMMATORY_RESPONSE_LPS
0.11366 0.14676BIOCARTA_ACH_PATHWAY
0.09234 0.08675NATSUME_RESPONSE_TO_INTERFERON_BETA_UP
0.03309 0.05146VALK_AML_WITH_CEBPA
0.01564 0.00291BIOCARTA_CASPASE_PATHWAY
0.17339 0.00594BENPORATH_PROLIFERATION
0.02646 0.00070AMIT_EGF_RESPONSE_60_MCF10A
0.01309 0.09632TSUNODA_CISPLATIN_RESISTANCE_UP
0.00000 0.00000KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION
0.01170 0.01388CHEN_HOXA5_TARGETS_6HR_UP
0.00021 0.00000SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
0.10835 0.05209NCI_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA
0.00255 0.00025RODWELL_AGING_KIDNEY_NO_BLOOD_UP
0.16438 0.09240BIOCARTA_FAS_PATHWAY
0.01232 0.00008LEONARD_HYPOXIA
0.04866 0.09030REACTOME_SIGNAL_AMPLIFICATION
0.00205 0.00071ROSS_AML_WITH_MLL_FUSIONS
0.19433 0.06248MMS_MOUSE_LYMPH_HIGH_4HRS_UP
0.12514 0.05224GOZGIT_ESR1_TARGETS_UP
0.04644 0.03472CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN
0.08777 0.05593CORUM_ITGA2B-ITGB3-CD47-FAK_COMPLEX
0.05633 0.04992FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN
0.11199 0.18373CHENG_RESPONSE_TO_NICKEL_ACETATE
0.00379 0.00095REACTOME_DOWNSTREAM_EVENTS_IN_GPCR_SIGNALING
0.00212 0.00729NCI_TOLL_LIKE_RECEPTOR_4__TLR4__CASCADE
0.01150 0.00166WU_CELL_MIGRATION
0.00000 0.00000WALLACE_PROSTATE_CANCER_RACE_UP
0.12123 0.01308BIOCARTA_CCR5_PATHWAY
0.15697 0.00574BASAKI_YBX1_TARGETS_UP
0.01431 0.01805KEGG_ECM_RECEPTOR_INTERACTION
0.07945 0.00443KEGG_MAPK_SIGNALING_PATHWAY
0.01407 0.04480SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN
0.05380 0.02499ONDER_CDH1_SIGNALING_VIA_CTNNB1
0.15904 0.02715GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN
0.00315 0.00119REACTOME_COLLAGEN_MEDIATED_ACTIVATION_CASCADE
0.06062 0.00376ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP
0.04055 0.00590AMUNDSON_GENOTOXIC_SIGNATURE
0.05970 0.13256CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN
0.00003 0.00252BIOCARTA_IL12_PATHWAY
0.00931 0.01539EHRLICH_ICF_SYNDROM_DN
0.00000 0.00001UROSEVIC_RESPONSE_TO_IMIQUIMOD
0.00262 0.00435BROWNE_HCMV_INFECTION_30MIN_UP
0.00000 0.00000TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP
0.00000 0.00000FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN
0.01714 0.00156CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP
0.01570 0.02669KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP
0.08924 0.03969MORI_SMALL_PRE_BII_LYMPHOCYTE_DN
0.06640 0.14050SANA_TNF_SIGNALING_DN
0.00017 0.00000REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL
0.01515 0.00826REACTOME_INNATE_IMMUNITY_SIGNALING
0.00000 0.00000REACTOME_HEMOSTASIS
0.01306 0.03050SWEET_LUNG_CANCER_KRAS_DN
0.00021 0.00274XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP
0.03271 0.10077LAIHO_COLORECTAL_CANCER_SERRATED_UP
0.00147 0.01675BIOCARTA_DC_PATHWAY
0.01498 0.01655ST_JAK_STAT_PATHWAY
0.00695 0.00104ROY_WOUND_BLOOD_VESSEL_UP
0.17707 0.01086TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN
0.13120 0.14846CORUM_IL4-IL4R-IL2RG_COMPLEX
0.15858 0.09591CORUM_ITGB3-ITGAV-CD47_COMPLEX
0.19857 0.14907CORUM_ITGA4-ITGB1-EMILIN1_COMPLEX
0.04168 0.02277CORUM_ITGA2B-ITGB3-CD47-SRC_COMPLEX
0.07936 0.10071WATANABE_COLON_CANCER_MSI_VS_MSS_UP
0.10978 0.02229REACTOME_P2Y_RECEPTORS
0.16639 0.00452REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS
0.18349 0.12161CORUM_ELMO1-DOCK2_COMPLEX
0.00000 0.00000GOLDRATH_ANTIGEN_RESPONSE
0.00550 0.07643BIOCARTA_TCRA_PATHWAY
0.00696 0.00024BILD_HRAS_ONCOGENIC_SIGNATURE
0.19070 0.11113FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN
0.01097 0.00307DAUER_STAT3_TARGETS_UP
0.00001 0.00000LIANG_SILENCED_BY_METHYLATION_2
0.17486 0.18462RIGGI_EWING_SARCOMA_PROGENITOR_DN
0.02832 0.14063WU_HBX_TARGETS_3_DN
0.00000 0.00122DER_IFN_ALPHA_RESPONSE_UP
0.02053 0.02619KEGG_DILATED_CARDIOMYOPATHY
0.12064 0.03256REACTOME_E2F_MEDIATED_REGULATION_OF_DNA_REPLICATION
0.06789 0.07768GRABARCZYK_BCL11B_TARGETS_UP
0.08846 0.10011CROONQUIST_IL6_DEPRIVATION_UP
0.00705 0.00358BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN
0.05909 0.00102AMIT_EGF_RESPONSE_60_HELA
0.02809 0.03269ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN
0.10697 0.01583NCI_P2Y_RECEPTORS
0.03944 0.00111DAZARD_UV_RESPONSE_CLUSTER_G2
0.06022 0.00632MARKS_HDAC_TARGETS_DN
0.08348 0.00163NCI_CD40_PATHWAY
0.00000 0.00000MCLACHLAN_DENTAL_CARIES_DN
0.00009 0.00014KEGG_ALLOGRAFT_REJECTION
0.00000 0.00000ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
0.03146 0.00595BIOCARTA_INFLAM_PATHWAY
0.00000 0.00000SANA_TNF_SIGNALING_UP
0.00454 0.00085THUM_SYSTOLIC_HEART_FAILURE_UP
0.15854 0.01080SENESE_HDAC1_AND_HDAC2_TARGETS_UP
0.00030 0.00003TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN
0.00000 0.00000ROSS_AML_WITH_CBFB_MYH11_FUSION
0.01857 0.01212NAKAJIMA_MAST_CELL
0.00610 0.01035BASSO_CD40_SIGNALING_DN
0.07823 0.00557MANALO_HYPOXIA_UP
0.00014 0.00260CASTELLANO_NRAS_TARGETS_UP
0.04910 0.01027GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP
0.00262 0.00004HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP
0.00000 0.00000KEGG_HEMATOPOIETIC_CELL_LINEAGE
0.05745 0.01268LEE_TARGETS_OF_PTCH1_AND_SUFU_DN
0.00029 0.00974SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2
0.02769 0.00103HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN
0.17433 0.11234NCI_TOLL_LIKE_RECEPTOR_TLR6_TLR2_CASCADE
0.00086 0.00340VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP
0.00001 0.00001KLEIN_TARGETS_OF_BCR_ABL1_FUSION
0.18334 0.03902CORUM_ITGAV-ITGB3-PXN-PTK2B_COMPLEX
0.02814 0.00336UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN
0.12303 0.05653BIOCARTA_KERATINOCYTE_PATHWAY
0.06196 0.10024BAELDE_DIABETIC_NEPHROPATHY_DN
0.06563 0.03128CORUM_LMO4-BRCA1-CTIP-LDB1_COMPLEX
0.01168 0.00140CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP
0.00766 0.01035CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP
0.00055 0.00031REACTOME_PLATELET_ACTIVATION_TRIGGERS
0.11029 0.05283KALMA_E2F1_TARGETS
0.01014 0.01174NETPATH_T_CELL_RECEPTOR_PATHWAY_UP
0.01558 0.00974HELLER_HDAC_TARGETS_DN
0.00087 0.00000CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN
0.00001 0.00009GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.12686 0.00531BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN
0.05925 0.06016GOUYER_TATI_TARGETS_UP
0.01306 0.00000ZHAN_MULTIPLE_MYELOMA_HP_UP
0.03292 0.04858NCI_GLUCOSE___ATP____GLUCOSE_6_PHOSPHATE___ADP
0.14311 0.11300NCI_LPS_TRANSFERRED_FROM_LBP_CARRIER_TO_CD14
0.14414 0.03222NCI_PDGFRBPATHWAY
0.00276 0.00009LU_IL4_SIGNALING
0.06405 0.02137NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN
0.00974 0.00053IVANOVA_HEMATOPOIESIS_MATURE_CELL
0.00144 0.01382WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN
0.06398 0.02573YAMASHITA_METHYLATED_IN_PROSTATE_CANCER
0.00587 0.01285NCI_VWF_INTERACTION_WITH_COLLAGEN
0.00000 0.00000KEGG_CITRATE_CYCLE_TCA_CYCLE
0.06932 0.00101NCI_BCR_5PATHWAY
0.00021 0.00547GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.06659 0.00699BIOCARTA_NFKB_PATHWAY
0.00000 0.00000LINDGREN_BLADDER_CANCER_CLUSTER_2B
0.00000 0.00000KEGG_GRAFT_VERSUS_HOST_DISEASE
0.06393 0.03409NIELSEN_LEIOMYOSARCOMA_UP
0.05834 0.00013VARELA_ZMPSTE24_TARGETS_UP
0.00094 0.00014REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS
0.16521 0.06530NCI_TNFPATHWAY
0.02389 0.10524CHEN_HOXA5_TARGETS_6HR_DN
0.00016 0.00014KRASNOSELSKAYA_ILF3_TARGETS_UP
0.00307 0.00001RASHI_RESPONSE_TO_IONIZING_RADIATION_2
0.05653 0.02073NCI_GPVI_MEDIATED_ACTIVATION_CASCADE
0.17528 0.14476CORUM_CDC2-PCNA-CCNB1-GADD45B_COMPLEX
0.03933 0.02903LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP
0.15676 0.08421DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_DN
0.09515 0.04073KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM
0.01123 0.00089GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN
0.04447 0.03375YAGI_AML_WITH_T_8_21_TRANSLOCATION
0.00041 0.00007LINDSTEDT_DENDRITIC_CELL_MATURATION_D
0.02326 0.00250VALK_AML_CLUSTER_1
0.03874 0.00042AMIT_EGF_RESPONSE_40_HELA
0.13166 0.01695ZHAN_EARLY_DIFFERENTIATION_GENES_DN
0.00386 0.00223CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN
0.09988 0.03497MITSIADES_RESPONSE_TO_APLIDIN_UP
0.00000 0.00000MORI_MATURE_B_LYMPHOCYTE_UP
0.01384 0.00174THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP
0.02725 0.00337XU_CREBBP_TARGETS_UP
0.00081 0.00001TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
0.19874 0.13788MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP
0.10988 0.08019ZHU_CMV_24_HR_DN
0.12590 0.04942KEGG_FOCAL_ADHESION
0.00055 0.00001HINATA_NFKB_TARGETS_KERATINOCYTE_UP
0.17468 0.07544MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_DN
0.08512 0.04484RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP
0.15979 0.10384CORUM_CD20-LCK-LYN-FYN-P75/80_COMPLEX_RAJI_HUMAN_B_CELL_LINE
0.00000 0.00000MARKEY_RB1_ACUTE_LOF_UP
0.06858 0.03444NCI_FRUCTOSE_6_PHOSPHATE_AND_ATP_REACT_TO_FORM_FRUCTOSE_2_6_BISPHOSPHATE_AND_ADP
0.02822 0.00833REN_ALVEOLAR_RHABDOMYOSARCOMA_DN
0.03622 0.00120SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP
0.00698 0.00053XU_AKT1_TARGETS_6HR
0.18721 0.04538REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS
0.05434 0.15989LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN
0.16421 0.08277HUANG_FOXA2_TARGETS_UP
0.09624 0.10943NCI_MYC_REPRESSPATHWAY
0.00000 0.00000POOLA_INVASIVE_BREAST_CANCER_UP
0.01934 0.00958TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN
0.08644 0.04362ZHAN_LATE_DIFFERENTIATION_GENES_DN
0.01711 0.00259RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN
0.00000 0.00000LIU_VAV3_PROSTATE_CARCINOGENESIS_UP
0.09330 0.06261CORUM_SH3P2/OSTF1-CBL-SRC_COMPLEX
0.04507 0.15100KORKOLA_TERATOMA
0.16678 0.07201SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP
0.15680 0.09836CASTELLANO_HRAS_TARGETS_DN
0.00007 0.00001DAUER_STAT3_TARGETS_DN
0.01936 0.09244REACTOME_PURINE_SALVAGE_REACTIONS
0.00181 0.00031RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN
0.10817 0.00066WU_APOPTOSIS_BY_CDKN1A_VIA_TP53
0.00000 0.00000KEGG_PEROXISOME
0.17047 0.08517CORUM_ITGAM-ITGB2-CD11_COMPLEX
0.00130 0.00067DANG_REGULATED_BY_MYC_DN
0.06101 0.05726NCI_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES
0.13821 0.10081CHEBOTAEV_GR_TARGETS_DN
0.11423 0.01689NCI_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTERGRINS_
0.00097 0.00095PARK_TRETINOIN_RESPONSE
0.08993 0.08927REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_12
0.13924 0.08703ZHANG_BREAST_CANCER_PROGENITORS_DN
0.18794 0.07358RUGO_RESPONSE_TO_4NQO
0.05216 0.04964IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_UP
0.00428 0.00028PODAR_RESPONSE_TO_ADAPHOSTIN_UP
0.00000 0.00000JAATINEN_HEMATOPOIETIC_STEM_CELL_DN
0.00000 0.00000HOSHIDA_LIVER_CANCER_SUBCLASS_S1
0.09153 0.05212DIRMEIER_LMP1_RESPONSE_LATE_DN
0.00021 0.00007KYNG_DNA_DAMAGE_UP
0.00000 0.00000LEE_LIVER_CANCER_E2F1_UP
0.00240 0.00255LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP
0.00007 0.00018DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN
0.02635 0.01106PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION
0.19486 0.12698WANG_SMARCE1_TARGETS_DN
0.08979 0.00250KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY
0.10037 0.02911CORUM_FYB-CARMA1-BCL-10-MALT1_COMPLEX
0.06718 0.00855KERLEY_RESPONSE_TO_CISPLATIN_UP
0.00213 0.00806ROETH_TERT_TARGETS_DN
0.05917 0.03696CORUM_G_PROTEIN_COMPLEX_BTK_GNG1_GNG2
0.00015 0.00001BOWIE_RESPONSE_TO_TAMOXIFEN
0.11694 0.09284NCI_S1P_S1P3_PATHWAY
0.00000 0.00000HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN
0.00000 0.00000ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP
0.00269 0.00012ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
0.12687 0.01300FERRANDO_LYL1_NEIGHBORS
0.12782 0.08086CORUM_SNX_COMPLEX_SNX1A_SNX2_SNX4_LEPR
0.05857 0.00363NETPATH_TGFBETA_RECEPTOR_PATHWAY_DOWN
0.02264 0.03169WONG_ENDMETRIUM_CANCER_UP
0.07466 0.03289FURUKAWA_DUSP6_TARGETS_PCI35_UP
0.06397 0.12994NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_DN
0.00638 0.00337FINAK_BREAST_CANCER_SDPP_SIGNATURE
0.01795 0.01643NETPATH_IL_3_PATHWAY_DOWN
0.00020 0.00000VANTVEER_BREAST_CANCER_ESR1_DN
0.00142 0.00064STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN
0.03205 0.10287PARK_APL_PATHOGENESIS_UP
0.00071 0.00130REACTOME_CD28_DEPENDENT_VAV1_PATHWAY
0.00013 0.00022REACTOME_TOLL_LIKE_RECEPTOR_4_CASCADE
0.00000 0.00000BROCKE_APOPTOSIS_REVERSED_BY_IL6
0.04899 0.01403BIOCARTA_D4GDI_PATHWAY
0.08881 0.00260LY_AGING_MIDDLE_DN
0.14534 0.05607CHANDRAN_METASTASIS_TOP50_DN
0.15675 0.00029EGUCHI_CELL_CYCLE_RB1_TARGETS
0.03619 0.04848KEGG_OTHER_GLYCAN_DEGRADATION
0.07476 0.03452NCI_P53DOWNSTREAMPATHWAY
0.05453 0.01258REACTOME_CD28_CO_STIMULATION
0.17969 0.09551CORUM_CONDENSIN_I_COMPLEX
0.00212 0.00020HUMMEL_BURKITTS_LYMPHOMA_DN
0.00000 0.00000GAL_LEUKEMIC_STEM_CELL_DN
0.00000 0.00005LEE_EARLY_T_LYMPHOCYTE_DN
0.00212 0.00020TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN
0.10738 0.06626CORUM_ITGA2B-ITGB3-TLN1_COMPLEX
0.00143 0.00093HUANG_DASATINIB_RESISTANCE_UP
0.00358 0.00151HINATA_NFKB_TARGETS_FIBROBLAST_UP
0.05028 0.13483WONG_ENDMETRIUM_CANCER_DN
0.11353 0.11417BIOCARTA_SET_PATHWAY
0.17763 0.16013NCI_ACTIVATION_AND_OLIGOMERIZATION_OF_BAK_PROTEIN
0.15179 0.00031REACTOME_RHO_GTPASE_CYCLE
0.06898 0.17385CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN
0.00075 0.00103KEGG_PRIMARY_IMMUNODEFICIENCY
0.19909 0.08549CORUM_CHROMOSOMAL_PASSENGER_COMPLEX_CPC_CDCA8_AURKB_BIRC5
0.00000 0.00000ZHANG_INTERFERON_RESPONSE
0.00135 0.00059CHANG_IMMORTALIZED_BY_HPV31_DN
0.13116 0.05650MOHANKUMAR_TLX1_TARGETS_DN
0.00000 0.00000MOOTHA_HUMAN_MITODB_6_2002
0.13557 0.01212KEGG_REGULATION_OF_ACTIN_CYTOSKELETON
0.00003 0.00006STEARMAN_TUMOR_FIELD_EFFECT_UP
0.00000 0.00000CROONQUIST_STROMAL_STIMULATION_UP
0.00466 0.00000KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION
0.00044 0.00483BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN
0.00011 0.00163CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP
0.07893 0.04795DORN_ADENOVIRUS_INFECTION_48HR_UP
0.07620 0.16490CORUM_BRCA1_B_COMPLEX
0.12494 0.03702ZHANG_RESPONSE_TO_CANTHARIDIN_UP
0.03918 0.00075KANG_IMMORTALIZED_BY_TERT_UP
0.00000 0.00000KHETCHOUMIAN_TRIM24_TARGETS_UP
0.02730 0.01992NAKAMURA_METASTASIS_MODEL_UP
0.02037 0.02859NCI_CD28_DEPENDENT_VAV1_PATHWAY
0.00931 0.04529OUYANG_PROSTATE_CANCER_PROGRESSION_UP
0.00147 0.00059HORIUCHI_WTAP_TARGETS_UP
0.18727 0.10115ONKEN_UVEAL_MELANOMA_UP
0.01387 0.02081NCI_CMYB_PATHWAY
0.00000 0.00000WOO_LIVER_CANCER_RECURRENCE_UP
0.02151 0.00518CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP
0.06516 0.03587CORUM_ITGA4-ITGB1-VCAM1_COMPLEX
0.14474 0.11413BIOCARTA_SODD_PATHWAY
0.12110 0.08699DORN_ADENOVIRUS_INFECTION_32HR_UP
0.04804 0.19572MCCABE_HOXC6_TARGETS_DN
0.04066 0.01998RIGGI_EWING_SARCOMA_PROGENITOR_UP
0.00111 0.00009BIOCARTA_TH1TH2_PATHWAY
0.18725 0.03891NCI_KITPATHWAY
0.01019 0.00097KEGG_JAK_STAT_SIGNALING_PATHWAY
0.04905 0.15497CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN
0.01307 0.01959BUDHU_LIVER_CANCER_METASTASIS_DN
0.02002 0.00000CROONQUIST_NRAS_SIGNALING_DN
0.00030 0.00214DER_IFN_BETA_RESPONSE_UP
0.00985 0.00944BOQUEST_STEM_CELL_DN
0.00013 0.00003MORI_PRE_BI_LYMPHOCYTE_DN
0.01306 0.00356TSAI_DNAJB4_TARGETS_UP
0.08673 0.16010CORUM_IL12B-IL12RB1-IL12RB2_COMPLEX
0.04997 0.00330GARY_CD5_TARGETS_UP
0.09165 0.00005NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP
0.00611 0.00141GILDEA_METASTASIS
0.07591 0.00395REACTOME_EICOSANOID_LIGAND_BINDING_RECEPTORS
0.04414 0.00491HAHTOLA_SEZARY_SYNDROM_UP
0.11742 0.02315RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN
0.00053 0.00000TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN
0.00000 0.00000BASSO_CD40_SIGNALING_UP
0.01499 0.00332MUELLER_METHYLATED_IN_GLIOBLASTOMA
0.06071 0.19700KEGG_OLFACTORY_TRANSDUCTION
0.07456 0.10270CHANG_POU5F1_TARGETS_UP
0.09628 0.00264TIAN_TNF_SIGNALING_NOT_VIA_NFKB
0.19766 0.11198KORKOLA_EMBRYONAL_CARCINOMA_UP
0.02945 0.00357IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR
0.15289 0.01034BIOCARTA_FCER1_PATHWAY
0.00648 0.00000NAGASHIMA_NRG1_SIGNALING_UP
0.01207 0.00359RAGHAVACHARI_PLATELET_SPECIFIC_GENES
0.07345 0.11589ZERBINI_RESPONSE_TO_SULINDAC_UP
0.00434 0.00010WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP
0.09080 0.03537NCI_PTP1BPATHWAY
0.09384 0.14751REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS
0.00513 0.00028SU_THYMUS
0.11152 0.04793SASSON_RESPONSE_TO_FORSKOLIN_DN
0.00000 0.00000SMID_BREAST_CANCER_NORMAL_LIKE_UP
0.19580 0.00337CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP
0.12888 0.01100AMUNDSON_GAMMA_RADIATION_RESISTANCE
0.06401 0.00035MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS
0.10955 0.06743REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION
0.07943 0.02560KEGG_VIRAL_MYOCARDITIS
0.00004 0.00603BIOCARTA_CTL_PATHWAY
0.15840 0.03557VERRECCHIA_RESPONSE_TO_TGFB1_C1
0.06898 0.00466ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN
0.00000 0.00000KEGG_LEISHMANIA_INFECTION
0.12061 0.03581NCI_CD28_CO_STIMULATION
0.03424 0.01090NUTT_GBM_VS_AO_GLIOMA_UP
0.02137 0.00005KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS
0.00274 0.01167REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY
0.00000 0.00000KEGG_TRYPTOPHAN_METABOLISM
0.06645 0.00619ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN
0.00006 0.00023YU_MYC_TARGETS_DN
0.09506 0.09055KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_OLD
0.12522 0.14733KANNAN_TP53_TARGETS_UP
0.01709 0.00291CHEN_HOXA5_TARGETS_9HR_UP
0.00405 0.01431NCI_NEF_AND_SIGNAL_TRANSDUCTION
0.05205 0.01783RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP
0.19310 0.08005CORUM_ITGAV-ITGB3-NOV_COMPLEX
0.00000 0.00000SEKI_INFLAMMATORY_RESPONSE_LPS_UP
0.02801 0.00975ST_GA12_PATHWAY
0.04101 0.16090KONDO_HYPOXIA
0.02756 0.08170GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_2
0.00007 0.00003GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP
0.19942 0.08446CORUM_PRB2/P130-MULTIMOLECULAR_COMPLEX_DNMT1_E2F5_SUV39H1_HDAC1_RBL2
0.10685 0.16013CORUM_ITGA4-PXN-GIT1_COMPLEX
0.06066 0.01806CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP
0.00000 0.00001PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION
0.00208 0.03366LEE_RECENT_THYMIC_EMIGRANT
0.03879 0.01538ENGELMANN_CANCER_PROGENITORS_UP
0.10119 0.03582REACTOME_P38MAPK_EVENTS
0.00000 0.00000LEE_DIFFERENTIATING_T_LYMPHOCYTE
0.11435 0.00276FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN
0.00000 0.00000FOSTER_INFLAMMATORY_RESPONSE_LPS_UP
0.00639 0.00252BIOCARTA_ASBCELL_PATHWAY
0.09820 0.03717SENESE_HDAC1_TARGETS_UP
0.03006 0.00731LIU_TARGETS_OF_VMYB_VS_CMYB_DN
0.02186 0.00111INGA_TP53_TARGETS
0.13365 0.00017KIM_WT1_TARGETS_UP
0.02300 0.00161PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP
0.00255 0.00440MORI_PLASMA_CELL_DN
0.01044 0.00252KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY
0.19139 0.09651HOLLMAN_APOPTOSIS_VIA_CD40_UP
0.00000 0.00000HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN
0.00000 0.00000CROONQUIST_NRAS_SIGNALING_UP
0.00929 0.01342IIZUKA_RECURRENT_LIVER_CANCER
0.07153 0.03041CUI_TCF21_TARGETS_DN
0.00000 0.00001BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP
0.10827 0.10522SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN
0.17743 0.12457CORUM_MCL1-BAK1_COMPLEX
0.00069 0.00288MATSUDA_NATURAL_KILLER_DIFFERENTIATION
0.11713 0.03882NCI_XANTHINE_FORMATION
0.01712 0.00473RUTELLA_RESPONSE_TO_HGF_UP
0.00000 0.00000HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP
0.07569 0.00099PRAMOONJAGO_SOX4_TARGETS_UP
0.00093 0.01018FERRANDO_TAL1_NEIGHBORS
0.18992 0.04364YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1
0.19587 0.02901LU_TUMOR_ENDOTHELIAL_MARKERS_UP
0.00515 0.00075VERHAAK_AML_WITH_NPM1_MUTATED_DN
0.00000 0.00000KEGG_FATTY_ACID_METABOLISM
0.00177 0.01687REACTOME_PD1_SIGNALING
0.13861 0.02348ROSS_LEUKEMIA_WITH_MLL_FUSIONS
0.01356 0.01105GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP
0.01308 0.00285BIOCARTA_PML_PATHWAY
0.00339 0.01016CORUM_RICH1/AMOT_POLARITY_COMPLEX_FLAG-RICH1_PRECIPITATED
0.18807 0.05648MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP
0.00012 0.00924BIOCARTA_NO2IL12_PATHWAY
0.00000 0.00000BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN
0.02631 0.04103SWEET_LUNG_CANCER_KRAS_UP
0.00093 0.00082BIOCARTA_TCYTOTOXIC_PATHWAY
0.00000 0.00000TENEDINI_MEGAKARYOCYTE_MARKERS
0.01307 0.00208HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_DN
0.15172 0.09001CONRAD_STEM_CELL
0.03916 0.13231SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN
0.00000 0.00000LINDSTEDT_DENDRITIC_CELL_MATURATION_A
0.11567 0.13155RUGO_UV_RESPONSE
0.01413 0.06012KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS
0.15013 0.18263BASAKI_YBX1_TARGETS_DN
0.03915 0.05395XU_RESPONSE_TO_TRETINOIN_UP
0.01170 0.00027ELVIDGE_HYPOXIA_UP
0.00000 0.00000REACTOME_PLATELET_ACTIVATION
0.01819 0.08004RADMACHER_AML_PROGNOSIS
0.00128 0.00033WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN
0.02639 0.07965GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_UP
0.09155 0.05678REACTOME_INTEGRIN_ALPHAIIBBETA3_SIGNALING
0.09924 0.01088SA_PROGRAMMED_CELL_DEATH
0.00089 0.00184HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP
0.18296 0.13378CORUM_CRM1-SURVIVIN-AURORAB_MITOTIC_COMPLEX
0.01450 0.08662WU_HBX_TARGETS_3_UP
0.12522 0.02530HO_LIVER_CANCER_VASCULAR_INVASION
0.01489 0.05819FRIDMAN_IMMORTALIZATION_DN
0.00856 0.16006ST_TYPE_I_INTERFERON_PATHWAY
0.00013 0.00000KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.19714 0.14332HOOI_ST7_TARGETS_DN
0.00128 0.00855BIOCARTA_NKCELLS_PATHWAY
0.08565 0.09635CORUM_PLC-GAMMA-2-SLP-76-LYN-GRB2_COMPLEX
0.12062 0.05349XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP
0.02454 0.01577VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP
0.00904 0.02045REACTOME_PHOSPHORYLATION_OF_CD3_AND_TCR_ZETA_CHAINS
0.04055 0.15069WILLIAMS_ESR2_TARGETS_DN
0.01255 0.02837BIOCARTA_IL22BP_PATHWAY
0.00153 0.00000PARK_APL_PATHOGENESIS_DN
0.06773 0.07268CORUM_SRC-PRKCD-CDCP1_COMPLEX
0.15485 0.06793SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_DN
0.02069 0.01553WIKMAN_ASBESTOS_LUNG_CANCER_DN
0.06893 0.02227KORKOLA_TERATOMA_UP
0.00020 0.00000DELYS_THYROID_CANCER_UP
0.00169 0.00000TSAI_RESPONSE_TO_IONIZING_RADIATION
0.00678 0.00348KRISHNAN_FURIN_TARGETS_UP
0.00000 0.00000DIRMEIER_LMP1_RESPONSE_EARLY
0.00899 0.00181KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION
0.12099 0.00269AMIT_SERUM_RESPONSE_240_MCF10A
0.01350 0.03886NCI_INTEGRIN_CELL_SURFACE_INTERACTIONS
0.00000 0.00000MARSON_FOXP3_TARGETS_UP
0.00000 0.00000BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS
0.00106 0.00163ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP
0.00605 0.08011GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP
0.03630 0.01648NCI_NFAT_TFPATHWAY
0.02809 0.00507ONDER_CDH1_TARGETS_3_DN
0.00017 0.00000TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN
0.11011 0.08083CORUM_BRCA1_C_COMPLEX
0.18180 0.15100SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN
0.13021 0.06671HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS
0.00000 0.00000NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP
0.00000 0.00000LIAN_LIPA_TARGETS_6M
0.11984 0.01067WINTER_HYPOXIA_METAGENE
0.08926 0.13241BROWNE_HCMV_INFECTION_8HR_UP
0.01103 0.00364MARKS_HDAC_TARGETS_UP
0.01549 0.00208MCBRYAN_PUBERTAL_BREAST_6_7WK_DN
0.00002 0.00008REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN
0.00572 0.00085TAVOR_CEBPA_TARGETS_UP
0.00002 0.00161PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP
0.04059 0.11655NETPATH_TNF_ALPHA_PATHWAY_UP
0.00573 0.00758NOJIMA_SFRP2_TARGETS_DN
0.00946 0.00014KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY
0.15614 0.11885BROWNE_HCMV_INFECTION_2HR_UP
0.00058 0.05336TAVOR_CEBPA_TARGETS_DN
0.17152 0.01412SESTO_RESPONSE_TO_UV_C3
0.00225 0.07481YANAGISAWA_LUNG_CANCER_RECURRENCE
0.02731 0.01485REACTOME_DEATH_RECEPTOR_SIGNALLING
0.00015 0.00030GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN
0.02816 0.16870NCI_ANTHRAXPATHWAY
0.00006 0.00014ZHAN_MULTIPLE_MYELOMA_DN
0.02292 0.00982NCI_CASPASE_PATHWAY
0.06588 0.02892NETPATH_IL_2_PATHWAY
0.00174 0.04195BIOCARTA_TCAPOPTOSIS_PATHWAY
0.19762 0.12340CORUM_PARVB-ARHGEF6_COMPLEX
0.09308 0.01959BIOCARTA_P38MAPK_PATHWAY
0.07719 0.00955REACTOME_AXON_GUIDANCE
0.00053 0.00000ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER
0.00446 0.00031GRANDVAUX_IRF3_TARGETS_UP
0.14399 0.13050HADDAD_B_LYMPHOCYTE_PROGENITOR
0.01548 0.00259ROZANOV_MMP14_TARGETS_UP
0.00053 0.00083ZHU_CMV_ALL_UP
0.01775 0.06977KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS
0.05110 0.10040NCI_SEMA4D_IN_SEMAPHORIN_SIGNALING
0.01569 0.00860REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING
0.04316 0.00628SCHLOSSER_SERUM_RESPONSE_UP
0.19133 0.14338CORUM_BRCA1-BARD1-UBCH7C_COMPLEX
0.13317 0.14237CORUM_TGF-BETA_RECEPTOR_II-TGF-BETA_RECEPTOR_I-TGF-BETA3_COMPLEX
0.19549 0.14274BIOCARTA_SPPA_PATHWAY
0.00021 0.00011LEE_LIVER_CANCER_HEPATOBLAST
0.00040 0.00000NAGASHIMA_EGF_SIGNALING_UP
0.02259 0.00056SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN
0.00153 0.00184KEGG_TYPE_I_DIABETES_MELLITUS
0.11440 0.00462AMIT_DELAYED_EARLY_GENES
0.00244 0.00003REACTOME_TCR_SIGNALING
0.00100 0.00020RUGO_STRESS_RESPONSE_SUBSET_H
0.01455 0.08006REACTOME_CLASSICAL_ANTIBODY_MEDIATED_COMPLEMENT_ACTIVATION
0.00117 0.00023KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION
0.16439 0.16197IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_DN
0.04356 0.02757CORUM_PLC-GAMMA-2-SYK-LAT-FCR-GAMMA_COMPLEX
0.01772 0.00340NOJIMA_SFRP2_TARGETS_UP
0.00610 0.00170RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP
0.00488 0.00301OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
0.09505 0.03931WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN
0.18032 0.00101WHITEFORD_PEDIATRIC_CANCER_MARKERS
0.01820 0.00085MARTINELLI_IMMATURE_NEUTROPHIL_DN
0.00000 0.00000BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN
0.00697 0.01045AUJLA_IL22_AND_IL17A_SIGNALING
0.02398 0.02395NCI_EPHRINBREVPATHWAY
0.18194 0.11650CORUM_BRCA1-CTIP-ZBRK1_REPRESSOR_COMPLEX
0.02448 0.00303ZHAN_MULTIPLE_MYELOMA_HP_DN
0.00006 0.00000LEE_LIVER_CANCER_MYC_TGFA_UP
0.06581 0.09031SCHUHMACHER_MYC_TARGETS_DN
0.16485 0.05342CORUM_ITGAV-ITGB3-COL4A3_COMPLEX
0.00000 0.00000LEE_LIVER_CANCER_DENA_UP
0.03101 0.00175HALMOS_CEBPA_TARGETS_UP
0.08566 0.03298NCI_A4B1_PAXINDEP_PATHWAY
0.01067 0.00855YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9
0.18335 0.04087ENK_UV_RESPONSE_EPIDERMIS_UP
0.00001 0.00000TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP
0.16670 0.08143CORUM_WIP-WASP-ACTIN-MYOSIN-IIA_COMPLEX
0.00127 0.00451SAGIV_CD24_TARGETS_DN
0.00235 0.00447REACTOME_MYD88_CASCADE
0.00000 0.00000WIELAND_UP_BY_HBV_INFECTION
0.00007 0.00022COATES_MACROPHAGE_M1_VS_M2_DN
0.00120 0.00042HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP
0.01435 0.02959ST_INTERFERON_GAMMA_PATHWAY
0.18500 0.08720MAHADEVAN_RESPONSE_TO_MP470_DN
0.18442 0.15056ZHAN_MULTIPLE_MYELOMA_CD1_UP
0.07823 0.12387LEE_INTRATHYMIC_T_PROGENITOR
0.00721 0.00034SMID_BREAST_CANCER_LUMINAL_A_DN
0.02983 0.00053TSAI_RESPONSE_TO_RADIATION_THERAPY
0.00320 0.02098NCI_CXCR3PATHWAY
0.16316 0.00635LU_TUMOR_ANGIOGENESIS_UP
0.14949 0.15802HUPER_BREAST_BASAL_VS_LUMINAL_DN
0.00160 0.00025HARRIS_HYPOXIA
0.02531 0.00015NETPATH_KIT_RECEPTOR_PATHWAY_UP
0.04142 0.07007REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTERGRINS_
0.00000 0.00000KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY
0.00000 0.00000KEGG_BUTANOATE_METABOLISM
0.07186 0.00596KARAKAS_TGFB1_SIGNALING
0.06939 0.05094NCI_BH3_ONLY_PROTEINS_ASSOCIATE_WITH_AND_INACTIVATE_ANTI_APOPTOTIC_BCL_2_MEMBERS
0.00614 0.00009RUIZ_TNC_TARGETS_DN
0.02806 0.00136WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER
0.09168 0.01034KAN_RESPONSE_TO_ARSENIC_TRIOXIDE
0.00000 0.00000DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN
0.00000 0.00000KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION
0.00003 0.00027SOUCEK_MYC_TARGETS
0.15834 0.12794ENGELMANN_CANCER_PROGENITORS_DN
0.00034 0.00005BILBAN_B_CLL_LPL_DN
0.16431 0.17802SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN
0.00262 0.00002KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY
0.00277 0.00408IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP
0.03124 0.15815TOMLINS_METASTASIS_DN
0.03548 0.01818OZANNE_AP1_TARGETS_UP
0.00000 0.00000ZHAN_MULTIPLE_MYELOMA_LB_DN
0.00000 0.00000LEE_LIVER_CANCER_SURVIVAL_UP
0.01760 0.00607KEGG_AUTOIMMUNE_THYROID_DISEASE
0.01161 0.00101TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP
0.00343 0.00767TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_DN
0.00000 0.00000FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP
0.16265 0.10861CORUM_CD20-LCK-FYN-P75/80_COMPLEX
0.09672 0.07843ZHAN_MULTIPLE_MYELOMA_SPIKED
0.05787 0.02449CHIN_BREAST_CANCER_COPY_NUMBER_UP
0.00152 0.00000LEE_LIVER_CANCER_ACOX1_UP
0.00000 0.00000RUTELLA_RESPONSE_TO_HGF_DN
0.15058 0.04554CORUM_ITGA4-ITGB1-THBS2_COMPLEX
0.08841 0.02738WANG_ESOPHAGUS_CANCER_PROGRESSION_UP
0.07399 0.07890BIOCARTA_GSK3_PATHWAY
0.00023 0.00004EINAV_INTERFERON_SIGNATURE_IN_CANCER
0.06393 0.03286LEI_MYB_TARGETS
0.18314 0.04027LEE_LIVER_CANCER_SURVIVAL_DN
0.17342 0.00974GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN
0.00705 0.00005AMIT_SERUM_RESPONSE_40_MCF10A
0.04611 0.00734PUJANA_ATM_PCC_NETWORK
0.11721 0.06950HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP
0.07828 0.06866BIDUS_METASTASIS_DN
0.01349 0.05932LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE
0.01566 0.04095CHIARETTI_T_ALL_RELAPSE_PROGNOSIS
0.00698 0.00557MAHADEVAN_IMATINIB_RESISTANCE_DN
0.04213 0.03615WONG_ENDOMETRIAL_CANCER_LATE
0.01254 0.01244BIOCARTA_HSP27_PATHWAY
0.00879 0.00442MARTINELLI_IMMATURE_NEUTROPHIL_UP
0.00000 0.00000ZHU_CMV_8_HR_UP
0.13801 0.13245GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP
0.03251 0.02732BIERIE_INFLAMMATORY_RESPONSE_TGFB1
0.12519 0.00411MARSON_FOXP3_TARGETS_DN
0.00104 0.00084TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP
0.00000 0.00000SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP
0.00000 0.00000DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP
0.03422 0.02073REACTOME_PECAM1_INTERACTIONS
0.03408 0.00223XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR
0.17108 0.08885EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP
0.00757 0.00036ONDER_CDH1_TARGETS_2_DN
0.02027 0.00529ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP
0.16622 0.04374ALCALAY_AML_BY_NPM1_LOCALIZATION_DN
0.09963 0.02396SENESE_HDAC3_TARGETS_UP
0.00000 0.00000LIAN_LIPA_TARGETS_3M
0.00000 0.00000KEGG_CHEMOKINE_SIGNALING_PATHWAY
0.00177 0.03830FUJII_YBX1_TARGETS_UP
0.08574 0.00241FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP
0.00100 0.00000CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN
0.01646 0.00063XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR
0.14466 0.00664NCI_RAC1_PATHWAY
0.00000 0.00000JISON_SICKLE_CELL_DISEASE_UP
0.06198 0.13588MCBRYAN_PUBERTAL_BREAST_3_4WK_DN
0.01304 0.03759BIOCARTA_CTLA4_PATHWAY
0.00356 0.00001XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP
0.00932 0.00567TARTE_PLASMA_CELL_VS_PLASMABLAST_UP
0.14492 0.03956DASU_IL6_SIGNALING_UP
0.00000 0.00000LEE_LIVER_CANCER_DENA_DN
0.15067 0.11431HUPER_BREAST_BASAL_VS_LUMINAL_UP
0.08919 0.01329CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP
0.00000 0.00000REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS
0.10538 0.00899ZUCCHI_METASTASIS_DN
0.00003 0.00000HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN
0.00001 0.00007DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN
0.00921 0.00078SMID_BREAST_CANCER_BASAL_UP
0.18688 0.06622FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP
0.01514 0.12345ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP
0.06897 0.01515NCI_TCRJNKPATHWAY
0.03624 0.00033LINDGREN_BLADDER_CANCER_CLUSTER_1_DN
0.00000 0.00000WINTER_HYPOXIA_DN